Gotto, Antonio M

Publications

Sort by

Co-Author Network

selected publications

Bempedoic acid in patients with type 2 diabetes mellitus, prediabetes, and normoglycaemia: A post hoc analysis of efficacy and glycaemic control using pooled data from phase 3 clinical trials. Diabetes, obesity & metabolism. 2022 Academic Article GET IT
Times cited: 17
High Free Cholesterol Bioavailability Drives the Tissue Pathologies in Scarb1^-/- Mice. Arteriosclerosis, thrombosis, and vascular biology. 2021 Academic Article GET IT
Times cited: 6
High-density lipoproteins, reverse cholesterol transport and atherogenesis. Nature reviews. Cardiology. 2021 Review GET IT
Times cited: 50
Association of Bempedoic Acid Administration With Atherogenic Lipid Levels in Phase 3 Randomized Clinical Trials of Patients With Hypercholesterolemia. JAMA cardiology. 2020 Review GET IT
Times cited: 96
Comparing a novel machine learning method to the Friedewald formula and Martin-Hopkins equation for low-density lipoprotein estimation. PloS one. 2020 Academic Article GET IT
Times cited: 15
Bempedoic acid safety analysis: Pooled data from four phase 3 clinical trials. Journal of clinical lipidology. 2020 Academic Article GET IT
Times cited: 42
Highly conserved amino acid residues in apolipoprotein A1 discordantly induce high density lipoprotein assembly in vitro and in vivo. Biochimica et biophysica acta. Molecular and cell biology of lipids. 2020 Academic Article GET IT
Times cited: 4
The Alcohol-High-Density Lipoprotein Athero-Protective Axis. Biomolecules. 2020 Review GET IT
Times cited: 6
PCSK9 and inflammation: a review of experimental and clinical evidence. European heart journal. Cardiovascular pharmacotherapy. 2019 Review GET IT
Times cited: 82
Intensive Lipid Lowering in Elderly Patients. JAMA cardiology. 2019 Comment GET IT
Times cited: 6
Mammalian Target of Rapamycin: A Metabolic Rheostat for Regulating Adipose Tissue Function and Cardiovascular Health. The American journal of pathology. 2019 Review GET IT
Times cited: 16
Cholesterol: Can't Live With It, Can't Live Without It. Methodist DeBakey cardiovascular journal. 2019 Review GET IT
Times cited: 8
Lipids and Cardiovascular Disease: Putting It All Together. Methodist DeBakey cardiovascular journal. 2019 Editorial Article GET IT
Times cited: 5
Revisiting Reverse Cholesterol Transport in the Context of High-Density Lipoprotein Free Cholesterol Bioavailability. Methodist DeBakey cardiovascular journal. 2019 Review GET IT
Times cited: 14
In Memoriam: Yuichiro Goto, MD (October 6, 1992 - May 28, 2003). Journal of atherosclerosis and thrombosis. 2018 Academic Article GET IT
Low-Density Lipoprotein Cholesterol and Cardiovascular Risk Reduction: How Low Is Low Enough Without Causing Harm?. JAMA cardiology. 2018 Editorial Article GET IT
Times cited: 2
Monocyte-to-HDL-cholesterol ratio as a prognostic marker in cardiovascular diseases. Journal of cellular physiology. 2018 Review GET IT
Times cited: 111
Rethinking reverse cholesterol transport and dysfunctional high-density lipoproteins. Journal of clinical lipidology. 2018 Review GET IT
Times cited: 29
Effect of fibrates on glycemic parameters: A systematic review and meta-analysis of randomized placebo-controlled trials. Pharmacological research. 2017 Review GET IT
Times cited: 17
Coronary Disease Survival with Diabetes. Cardiology. 2017 Editorial Article GET IT
Lipid-modifying activity of curcuminoids: A systematic review and meta-analysis of randomized controlled trials. Critical reviews in food science and nutrition. 2017 Review GET IT
Times cited: 44
ABCA1-Derived Nascent High-Density Lipoprotein-Apolipoprotein AI and Lipids Metabolically Segregate. Arteriosclerosis, thrombosis, and vascular biology. 2017 Academic Article GET IT
Times cited: 26
Effect of soy isoflavone supplementation on plasma lipoprotein(a) concentrations: A meta-analysis. Journal of clinical lipidology. 2017 Review GET IT
Times cited: 17
HDL functionality in familial hypercholesterolemia: effects of treatment modalities and pharmacological interventions. Drug discovery today. 2017 Review GET IT
Times cited: 16
Structural Stability of Streptococcal Serum Opacity Factor. The protein journal. 2017 Academic Article GET IT
Update on the use of PCSK9 inhibitors in adults: Recommendations from an Expert Panel of the National Lipid Association. Journal of clinical lipidology. 2017 Academic Article GET IT
Times cited: 81
Scavenger receptor B1 (SR-B1) profoundly excludes high density lipoprotein (HDL) apolipoprotein AII as it nibbles HDL-cholesteryl ester. The Journal of biological chemistry. 2017 Academic Article GET IT
Times cited: 25
Neo High-Density Lipoprotein Produced by the Streptococcal Serum Opacity Factor Activity against Human High-Density Lipoproteins Is Hepatically Removed via Dual Mechanisms. Biochemistry. 2016 Academic Article GET IT
Times cited: 4
Acylation of lysine residues in human plasma high density lipoprotein increases stability and plasma clearance in vivo. Biochimica et biophysica acta. 2016 Academic Article GET IT
Pitavastatin Differentially Modulates MicroRNA-Associated Cholesterol Transport Proteins in Macrophages. PloS one. 2016 Academic Article GET IT
Times cited: 8
Speciated High-Density Lipoprotein Biogenesis and Functionality. Current atherosclerosis reports. 2016 Review GET IT
Times cited: 8
Integrated Measure for Atherogenic Lipoproteins in the Modern Era: Risk Assessment Based on Apolipoprotein B. Journal of the American College of Cardiology. 2016 Editorial Article GET IT
Times cited: 4
A survey of patient expectations regarding sexual function following radical prostatectomy. BJU international. 2016 Academic Article GET IT
Times cited: 23
Streptococcal serum opacity factor promotes cholesterol ester metabolism and bile acid secretion in vitro and in vivo. Biochimica et biophysica acta. 2015 Academic Article GET IT
Times cited: 4
New Insights into the High-Density Lipoprotein Dilemma. Trends in endocrinology and metabolism: TEM. 2015 Review GET IT
Times cited: 16
Statin Intolerance: the Clinician's Perspective. Current atherosclerosis reports. 2015 Review GET IT
Times cited: 41
The low-density lipoprotein hypothesis: Proven again with the Improved Reduction of Outcomes: Vytorin Efficacy International Trial. Journal of clinical lipidology. 2015 Editorial Article GET IT
Times cited: 1
Apolipoprotein AI deficiency inhibits serum opacity factor activity against plasma high density lipoprotein via a stabilization mechanism. Biochemistry. 2015 Academic Article GET IT
Times cited: 5
The effect of statin therapy on heart failure events: a collaborative meta-analysis of unpublished data from major randomized trials. European heart journal. 2015 Review GET IT
Times cited: 113
Alcohol: a nutrient with multiple salutary effects. Nutrients. 2015 Review GET IT
Times cited: 8
High-Density Lipoprotein Processing and Premature Cardiovascular Disease. Methodist DeBakey cardiovascular journal. 2015 Review GET IT
Times cited: 4
Effects of anacetrapib on plasma lipids in specific patient subgroups in the DEFINE (Determining the Efficacy and Tolerability of CETP INhibition with AnacEtrapib) trial. Journal of clinical lipidology. 2014 Academic Article GET IT
Times cited: 23
Optimizing statin treatment. Trends in cardiovascular medicine. 2014 Editorial Article GET IT
Development of a nomogram model predicting current bone scan positivity in patients treated with androgen-deprivation therapy for prostate cancer. Frontiers in oncology. 2014 Academic Article GET IT
Times cited: 64
HMG-coenzyme A reductase inhibition, type 2 diabetes, and bodyweight: evidence from genetic analysis and randomised trials. Lancet (London, England). 2014 Review GET IT
Times cited: 482
Very low levels of atherogenic lipoproteins and the risk for cardiovascular events: a meta-analysis of statin trials. Journal of the American College of Cardiology. 2014 Review GET IT
Times cited: 450
The role of PTEN tumor suppressor pathway staining in carcinoma in situ of the bladder. Urologic oncology. 2014 Academic Article GET IT
Times cited: 19
Merits and potential downsides of the 2013 ACC/AHA cholesterol management guidelines. Nutrition, metabolism, and cardiovascular diseases : NMCD. 2014 Academic Article GET IT
Times cited: 8
Lipids, safety parameters, and drug concentrations after an additional 2 years of treatment with anacetrapib in the DEFINE study. Journal of cardiovascular pharmacology and therapeutics. 2014 Academic Article GET IT
Times cited: 35
Gastric variceal bleeding due to pancreatitis-induced splenic vein thrombosis. 2014 GET IT
Times cited: 5
Residual macrovascular risk in 2013: what have we learned?. Cardiovascular diabetology. 2014 Review GET IT
Times cited: 133
Diversity efforts, admissions, and national rankings: can we align priorities?. Teaching and learning in medicine. 2014 Academic Article GET IT
Times cited: 16
Evaluation of lipids, drug concentration, and safety parameters following cessation of treatment with the cholesteryl ester transfer protein inhibitor anacetrapib in patients with or at high risk for coronary heart disease. The American journal of cardiology. 2013 Academic Article GET IT
Times cited: 72
Prevalence of the apolipoprotein E Arg145Cys dyslipidemia at-risk polymorphism in African-derived populations. The American journal of cardiology. 2013 Academic Article GET IT
Times cited: 12
Setting the course for apoAII: a port in sight?. Clinical lipidology. 2013 Academic Article GET IT
Times cited: 10
Benefits of statins in elderly subjects without established cardiovascular disease: a meta-analysis. Journal of the American College of Cardiology. 2013 Review GET IT
Times cited: 185
Levels and changes of HDL cholesterol and apolipoprotein A-I in relation to risk of cardiovascular events among statin-treated patients: a meta-analysis. Circulation. 2013 Review GET IT
Times cited: 151
Pharmacotherapies for lipid modification: beyond the statins. Nature reviews. Cardiology. 2013 Review GET IT
Times cited: 38
When clinical trials fail to address treatment gaps: the failure of niacin-laropiprant to reduce cardiovascular events. Current atherosclerosis reports. 2013 Comment GET IT
Times cited: 4
Biological relevance of inflammation and oxidative stress in the pathogenesis of arterial diseases. The American journal of pathology. 2013 Review GET IT
Times cited: 124
Statin therapy and outcome after ischemic stroke: systematic review and meta-analysis of observational studies and randomized trials. Stroke. 2013 Review GET IT
Times cited: 187
Measurement of LDL-C after treatment with the CETP inhibitor anacetrapib. Journal of lipid research. 2012 Academic Article GET IT
Times cited: 42
Safety of inhibition of cholesteryl ester transfer protein with anacetrapib: the DEFINE study. Expert review of cardiovascular therapy. 2012 Review GET IT
Times cited: 22
Management of cardiovascular risk: the importance of meeting lipid targets. The American journal of cardiology. 2012 Review GET IT
Times cited: 61
Recent clinical studies of the effects of lipid-modifying therapies. The American journal of cardiology. 2012 Review GET IT
Times cited: 38
Update on the evaluation and management of cardiovascular risk. Introduction. The American journal of cardiology. 2012 Article GET IT
Association of LDL cholesterol, non-HDL cholesterol, and apolipoprotein B levels with risk of cardiovascular events among patients treated with statins: a meta-analysis. JAMA. 2012 Review GET IT
Times cited: 593
The editor's roundtable: JUPITER follow-up. The American journal of cardiology. 2011 Academic Article GET IT
Times cited: 2
Age, obesity, medical comorbidities and surgical technique are predictive of symptomatic anastomotic strictures after contemporary radical prostatectomy. The Journal of urology. 2011 Academic Article GET IT
Times cited: 44
Outcomes after resection of postchemotherapy residual neck mass in patients with germ cell tumors--an update. Urology. 2011 Academic Article GET IT
Times cited: 11
Predictors of symptomatic lymphocele after radical prostatectomy and bilateral pelvic lymph node dissection. International journal of urology : official journal of the Japanese Urological Association. 2011 Academic Article GET IT
Times cited: 50
The editor's roundtable: Closing the clinical practice gap-using evidence-based treatments for managing lipids. The American journal of cardiology. 2011 Review GET IT
Jeremiah Metzger Lecture: cholesterol, inflammation and atherosclerotic cardiovascular disease: is it all LDL?. Transactions of the American Clinical and Climatological Association. 2011 Conference Paper GET IT
Times cited: 38
Safety of anacetrapib in patients with or at high risk for coronary heart disease. The New England journal of medicine. 2010 Academic Article GET IT
Times cited: 686
Important considerations in the clinical use of preoperative prostate cancer predictive nomograms. European urology. 2010 Letter GET IT
Pitavastatin for the treatment of primary hyperlipidemia and mixed dyslipidemia. Expert review of cardiovascular therapy. 2010 Review GET IT
Times cited: 14
HDL cholesterol and residual risk of first cardiovascular events after treatment with potent statin therapy: an analysis from the JUPITER trial. Lancet (London, England). 2010 Academic Article GET IT
Times cited: 205
Impact of prior prostate radiation on complications after radical prostatectomy. The Journal of urology. 2010 Academic Article GET IT
Times cited: 119
Relation of different measures of low-density lipoprotein cholesterol to risk of coronary artery disease and death in a meta-regression analysis of large-scale trials of statin therapy. The American journal of cardiology. 2010 Review GET IT
Times cited: 46
Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials. Lancet (London, England). 2010 Review GET IT
Times cited: 1939
Surgery for retroperitoneal relapse in the setting of a prior retroperitoneal lymph node dissection for germ cell tumor. Indian journal of urology : IJU : journal of the Urological Society of India. 2010 Academic Article GET IT
Times cited: 2
Candidate genetic analysis of plasma high-density lipoprotein-cholesterol and severity of coronary atherosclerosis. BMC medical genetics. 2009 Academic Article GET IT
Times cited: 40
Design of the DEFINE trial: determining the EFficacy and tolerability of CETP INhibition with AnacEtrapib. American heart journal. 2009 Academic Article GET IT
Times cited: 79
Number needed to treat with rosuvastatin to prevent first cardiovascular events and death among men and women with low low-density lipoprotein cholesterol and elevated high-sensitivity C-reactive protein: justification for the use of statins in prevention: an intervention trial evaluating rosuvastatin (JUPITER). Circulation. Cardiovascular quality and outcomes. 2009 Academic Article GET IT
Times cited: 117
Effects of increasing high-density lipoprotein cholesterol and decreasing low-density lipoprotein cholesterol on the incidence of first acute coronary events (from the Air Force/Texas Coronary Atherosclerosis Prevention Study). The American journal of cardiology. 2009 Academic Article GET IT
Times cited: 52
The benefits of statins in people without established cardiovascular disease but with cardiovascular risk factors: meta-analysis of randomised controlled trials. BMJ (Clinical research ed.). 2009 Review GET IT
Times cited: 677
Improving lipid goal attainment: is it enough?. Circulation. 2009 Editorial Article GET IT
Times cited: 5
Atherosclerosis in LDLR-knockout mice is inhibited, but not reversed, by the PPARgamma ligand pioglitazone. The American journal of pathology. 2009 Academic Article GET IT
Times cited: 27
A randomized trial of rosuvastatin in the prevention of venous thromboembolism. The New England journal of medicine. 2009 Academic Article GET IT
Times cited: 616
Reduction in C-reactive protein and LDL cholesterol and cardiovascular event rates after initiation of rosuvastatin: a prospective study of the JUPITER trial. Lancet (London, England). 2009 Academic Article GET IT
Times cited: 854
The 9p21 susceptibility locus for coronary artery disease and the severity of coronary atherosclerosis. BMC cardiovascular disorders. 2009 Academic Article GET IT
Times cited: 39
Pitavastatin suppresses mitogen activated protein kinase-mediated Erg-1 induction in human vascular smooth muscle cells. European journal of pharmacology. 2009 Academic Article GET IT
Times cited: 8
Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. The New England journal of medicine. 2008 Academic Article GET IT
Times cited: 5376
Ethical issues and global health. Academic medicine : journal of the Association of American Medical Colleges. 2008 Letter GET IT
Activation of peroxisome proliferator-activated receptor-alpha in mice induces expression of the hepatic low-density lipoprotein receptor. British journal of pharmacology. 2008 Academic Article GET IT
Times cited: 40
Genetic deletion of low density lipoprotein receptor impairs sterol-induced mouse macrophage ABCA1 expression. A new SREBP1-dependent mechanism. The Journal of biological chemistry. 2007 Academic Article GET IT
Times cited: 28
Baseline characteristics of participants in the JUPITER trial, a randomized placebo-controlled primary prevention trial of statin therapy among individuals with low low-density lipoprotein cholesterol and elevated high-sensitivity C-reactive protein. The American journal of cardiology. 2007 Academic Article GET IT
Times cited: 110
HDL cholesterol, very low levels of LDL cholesterol, and cardiovascular events. The New England journal of medicine. 2007 Academic Article GET IT
Times cited: 1313
Does torcetrapib reduce the progression of atherosclerotic disease?. Nature clinical practice. Cardiovascular medicine. 2007 Comment GET IT
Times cited: 5
Treatment of HIV-associated dyslipidemia: a role for omega-3 fatty acids. The AIDS reader. 2007 Review GET IT
Times cited: 10
A trilogy of primary prevention statin trials. Panel discussion. Atherosclerosis. Supplements. 2007 Conference Paper GET IT
Times cited: 4
Establishing the benefit of statins in low-to-moderate--risk primary prevention: the Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS). Atherosclerosis. Supplements. 2007 Academic Article GET IT
Times cited: 14
Anti-adipogenic action of pitavastatin occurs through the coordinate regulation of PPARgamma and Pref-1 expression. British journal of pharmacology. 2007 Academic Article GET IT
Times cited: 43
Statin therapy and the elderly: SAGE advice?. Circulation. 2007 Editorial Article GET IT
Times cited: 24
Role of C-reactive protein in coronary risk reduction: focus on primary prevention. The American journal of cardiology. 2007 Review GET IT
Times cited: 37
Cardiologist's role in improving glucose control and global cardiovascular risk in patients with type 2 diabetes mellitus. The American journal of cardiology. 2006 Review GET IT
Times cited: 8
The Editor's Roundtable: the metabolic syndrome. The American journal of cardiology. 2006 Article GET IT
Times cited: 6
Drug insight: the role of statins in combination with ezetimibe to lower LDL cholesterol. Nature clinical practice. Cardiovascular medicine. 2006 Review GET IT
Times cited: 18
Effects of high-dose atorvastatin on cerebrovascular events in patients with stable coronary disease in the TNT (treating to new targets) study. Journal of the American College of Cardiology. 2006 Academic Article GET IT
Times cited: 63
Is it appropriate to make statins available over the counter? Over-the-counter statins are worth considering in primary prevention of cardiovascular disease. Circulation. 2006 Academic Article GET IT
Times cited: 15
Is it appropriate to make statins available over the counter? The argument against the appropriateness of over-the-counter statins. Circulation. 2006 Comment GET IT
Times cited: 9
The metabolic syndrome: a call to action. Coronary artery disease. 2006 Review GET IT
Times cited: 37
Statins, cardiovascular disease, and drug safety. The American journal of cardiology. 2006 Review GET IT
Times cited: 57
The evolution of European guidelines: changing the management of cholesterol levels. Atherosclerosis. 2005 Review GET IT
Times cited: 18
Implications from the Air Force/Texas Coronary Atherosclerosis Prevention Study for the Adult Treatment Panel III guidelines. The American journal of cardiology. 2005 Academic Article GET IT
Times cited: 23
Building a transcontinental affiliation: a new model for academic health centers. Academic medicine : journal of the Association of American Medical Colleges. 2005 Academic Article GET IT
Times cited: 5
The benefits of statin therapy--what questions remain?. Clinical cardiology. 2005 Review GET IT
Times cited: 7
Evolving concepts of dyslipidemia, atherosclerosis, and cardiovascular disease: the Louis F. Bishop Lecture. Journal of the American College of Cardiology. 2005 Review GET IT
Times cited: 39
Review of primary and secondary prevention trials with lovastatin, pravastatin, and simvastatin. The American journal of cardiology. 2005 Review GET IT
Times cited: 48
Over-the-counter statins and cardiovascular disease prevention: perspectives, challenges, and opportunities. Clinical pharmacology and therapeutics. 2005 Academic Article GET IT
Times cited: 11
Should patients with combined hyperlipidemia receive statin-fibrate combination therapy?. Nature clinical practice. Cardiovascular medicine. 2005 Academic Article GET IT
A common PCSK9 haplotype, encompassing the E670G coding single nucleotide polymorphism, is a novel genetic marker for plasma low-density lipoprotein cholesterol levels and severity of coronary atherosclerosis. Journal of the American College of Cardiology. 2005 Academic Article GET IT
Times cited: 125
Intensive lipid lowering with atorvastatin in patients with stable coronary disease. The New England journal of medicine. 2005 Academic Article GET IT
Times cited: 3051
A randomized trial of a strategy for increasing high-density lipoprotein cholesterol levels: effects on progression of coronary heart disease and clinical events. Annals of internal medicine. 2005 Academic Article GET IT
Times cited: 213
Efficacy and safety of statin therapy in children with familial hypercholesterolemia: a randomized controlled trial. The Journal of pediatrics. 2005 Comment GET IT
Functional interplay between the macrophage scavenger receptor class B type I and pitavastatin (NK-104). Circulation. 2004 Academic Article GET IT
Times cited: 52
The case for over-the-counter statins. The American journal of cardiology. 2004 Review GET IT
Times cited: 10
Update on statins: 2003. Circulation. 2004 Review GET IT
Times cited: 210
Intensive versus moderate lipid lowering with statins after acute coronary syndromes. The New England journal of medicine. 2004 Letter GET IT
Times cited: 1
Targeting high-risk young patients for statin therapy. JAMA. 2004 Editorial Article GET IT
Times cited: 7
C-reactive protein and coronary heart disease. The New England journal of medicine. 2004 Letter GET IT
Times cited: 13
HDL cholesterol and protective factors in atherosclerosis. Circulation. 2004 Review GET IT
Times cited: 439
Inflammation in atherosclerosis and implications for therapy. Circulation. 2004 Review GET IT
Times cited: 302
K/DOQI clinical practice guidelines on hypertension and antihypertensive agents in chronic kidney disease. 2004 GET IT
Times cited: 1052
Past, present, and future standards for management of dyslipidemia. The American journal of medicine. 2004 Review GET IT
Times cited: 12
Assessing low levels of high-density lipoprotein cholesterol as a risk factor in coronary heart disease: a working group report and update. Journal of the American College of Cardiology. 2004 Review GET IT
Times cited: 207
Pitavastatin downregulates expression of the macrophage type B scavenger receptor, CD36. Circulation. 2004 Academic Article GET IT
Times cited: 77
The metabolic syndrome and risk of major coronary events in the Scandinavian Simvastatin Survival Study (4S) and the Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS). The American journal of cardiology. 2004 Academic Article GET IT
Times cited: 448
Effects of PPARalpha, gamma and delta haplotypes on plasma levels of lipids, severity and progression of coronary atherosclerosis and response to statin therapy in the lipoprotein coronary atherosclerosis study. Pharmacogenetics. 2004 Academic Article GET IT
Times cited: 50
Pitavastatin alters the expression of thrombotic and fibrinolytic proteins in human vascular cells. Journal of cellular biochemistry. 2003 Academic Article GET IT
Times cited: 45
NCEP ATP III guidelines incorporate global risk assessment. The American journal of managed care. 2003 Academic Article GET IT
Times cited: 10
Adipogenic differentiating agents regulate expression of fatty acid binding protein and CD36 in the J744 macrophage cell line. Journal of lipid research. 2003 Academic Article GET IT
Times cited: 53
The Heart Protection Study: expanding the boundaries for high-risk coronary disease prevention. The American journal of cardiology. 2003 Review GET IT
Times cited: 30
High density lipoproteins (HDLs) and atherosclerosis; the unanswered questions. Atherosclerosis. 2003 Review GET IT
Times cited: 188
Targeting CD36: modulating inflammation and atherogenesis. Current atherosclerosis reports. 2003 Review GET IT
Times cited: 4
Antioxidants, statins, and atherosclerosis. Journal of the American College of Cardiology. 2003 Review GET IT
Times cited: 69
Risks and benefits of continued aggressive statin therapy. Clinical cardiology. 2003 Review GET IT
Times cited: 18
Safety and statin therapy: reconsidering the risks and benefits. Archives of internal medicine. 2003 Editorial Article GET IT
Times cited: 58
Treating hypercholesterolemia: looking forward. Clinical cardiology. 2003 Review GET IT
Times cited: 26
High density lipoprotein: guardian of the vascular system?. International journal of clinical practice. 2002 Review GET IT
Times cited: 17
High-density lipoprotein cholesterol and triglycerides as therapeutic targets for preventing and treating coronary artery disease. American heart journal. 2002 Review GET IT
Times cited: 104
New options in lipid management--can we extend the benefits of current therapy? Introduction. American heart journal. 2002 Review GET IT
Reducing the risk for stroke in patients with myocardial infarction: a Myocardial Ischemia Reduction with Aggressive Cholesterol Lowering (MIRACL) substudy. Circulation. 2002 Editorial Article GET IT
Times cited: 10
Effects of SREBF-1a and SCAP polymorphisms on plasma levels of lipids, severity, progression and regression of coronary atherosclerosis and response to therapy with fluvastatin. Journal of molecular medicine (Berlin, Germany). 2002 Academic Article GET IT
Times cited: 44
In memoriam Donald S. Fredrickson, MD: 1924-2002. Arteriosclerosis, thrombosis, and vascular biology. 2002 Academic Article GET IT
Times cited: 1
Lipid management in diabetic patients: lessons from prevention trials. The American journal of medicine. 2002 Review GET IT
Times cited: 44
Management of dyslipidemia. The American journal of medicine. 2002 Review GET IT
Times cited: 50
Plasma homocysteine concentration, statin therapy, and the risk of first acute coronary events. Circulation. 2002 Academic Article GET IT
Times cited: 61
Regulation of peroxisome proliferator-activated receptor-gamma-mediated gene expression. A new mechanism of action for high density lipoprotein. The Journal of biological chemistry. 2002 Academic Article GET IT
Times cited: 58
The cardiology patient page. Statins: powerful drugs for lowering cholesterol: advice for patients. Circulation. 2002 Academic Article GET IT
Times cited: 22
Comparison of effects on low-density lipoprotein cholesterol and high-density lipoprotein cholesterol with rosuvastatin versus atorvastatin in patients with type IIa or IIb hypercholesterolemia. The American journal of cardiology. 2002 Academic Article GET IT
Times cited: 240
K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. 2002 GET IT
Times cited: 11695
Eligibility for lipid-lowering drug therapy in primary prevention: how do the Adult Treatment Panel II and Adult Treatment Panel III Guidelines compare?. Circulation. 2002 Editorial Article GET IT
Times cited: 10
Dyslipidemia and the vulnerable plaque. Progress in cardiovascular diseases. 2002 Review GET IT
Times cited: 24
Review of clinical trial data reaffirms safety of statin therapy. The American journal of managed care. 2002 Academic Article GET IT
Times cited: 1
Statins and C-reactive protein: considering a novel marker of cardiovascular risk. Preventive cardiology. 2002 Review GET IT
Times cited: 12
Undertreatment of dyslipidemia in peripheral arterial disease and other high-risk populations: an opportunity for cardiovascular disease reduction. Vascular medicine (London, England). 2002 Review GET IT
Times cited: 31
Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS): efficacy and tolerability of long-term treatment with lovastatin in women. Journal of women's health & gender-based medicine. 2001 Academic Article GET IT
Times cited: 90
AHA/ACC Guidelines for Preventing Heart Attack and Death in Patients With Atherosclerotic Cardiovascular Disease: 2001 update. A statement for healthcare professionals from the American Heart Association and the American College of Cardiology. 2001 GET IT
Times cited: 240
Emerging perspectives on lipid management: international approaches and global challenges. The American journal of cardiology. 2001 Editorial Article GET IT
Times cited: 3
AHA/ACC Scientific Statement: AHA/ACC guidelines for preventing heart attack and death in patients with atherosclerotic cardiovascular disease: 2001 update: A statement for healthcare professionals from the American Heart Association and the American College of Cardiology. Circulation. 2001 Academic Article GET IT
Times cited: 546
Ongoing clinical trials of statins. The American journal of cardiology. 2001 Review GET IT
Times cited: 22
How do we achieve optimal cardiovascular risk reduction?. Clinical cardiology. 2001 Review GET IT
Times cited: 4
Pleiotropic effects of statins: do they matter?. Current opinion in lipidology. 2001 Review GET IT
Times cited: 78
Measurement of C-reactive protein for the targeting of statin therapy in the primary prevention of acute coronary events. The New England journal of medicine. 2001 Academic Article GET IT
Times cited: 1495
Novel polymorphisms in promoter region of atp binding cassette transporter gene and plasma lipids, severity, progression, and regression of coronary atherosclerosis and response to therapy. Circulation research. 2001 Academic Article GET IT
Times cited: 92
Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TEXCAPS): additional perspectives on tolerability of long-term treatment with lovastatin. The American journal of cardiology. 2001 Academic Article GET IT
Times cited: 116
In memoriam: Robert I. Levy 1937-2000. Journal of lipid research. 2001 Academic Article GET IT
Times cited: 1
Low high-density lipoprotein cholesterol as a risk factor in coronary heart disease: a working group report. Circulation. 2001 Conference Paper GET IT
Times cited: 99
Primary prevention of coronary heart disease: where do we go from here?. Archives of internal medicine. 2001 Editorial Article GET IT
Times cited: 5
High-density lipoprotein cholesterol: an updated view. Current opinion in pharmacology. 2001 Review GET IT
Times cited: 5
Statin therapy: where are we? Where do we go next?. The American journal of cardiology. 2001 Review GET IT
Times cited: 40
A prospective study of paraoxonase gene Q/R192 polymorphism and severity, progression and regression of coronary atherosclerosis, plasma lipid levels, clinical events and response to fluvastatin. Atherosclerosis. 2001 Academic Article GET IT
Times cited: 50
Oxidized low density lipoprotein decreases macrophage expression of scavenger receptor B-I. The Journal of biological chemistry. 2001 Academic Article GET IT
Times cited: 62
Effect of lovastatin on cardiovascular resource utilization and costs in the Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS). AFCAPS/TexCAPS Research Group. The American journal of cardiology. 2000 Academic Article GET IT
Times cited: 32
Risk reduction. Circulation. 2000 Review GET IT
Times cited: 35
Apolipoprotein E genotypes and response of plasma lipids and progression-regression of coronary atherosclerosis to lipid-lowering drug therapy. Journal of the American College of Cardiology. 2000 Academic Article GET IT
Times cited: 80
Roundtable discussion. Achieving more aggressive low-density lipoprotein cholesterol lowering. The American journal of managed care. 2000 Academic Article GET IT
Application of the National Cholesterol Education Program and joint European treatment criteria and clinical benefit in the Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS). European heart journal. 2000 Academic Article GET IT
Times cited: 14
Plasma lipids and other cardiovascular risk factors in Costa Rican adolescents. Revista panamericana de salud publica = Pan American journal of public health. 2000 Academic Article GET IT
Times cited: 9
Insights on treating an over-the-counter-type subgroup: data from the Air Force/Texas Coronary Atherosclerosis Prevention Study Population. The American journal of cardiology. 2000 Review GET IT
Times cited: 12
Induction of CD36 expression by oxidized LDL and IL-4 by a common signaling pathway dependent on protein kinase C and PPAR-gamma. Journal of lipid research. 2000 Academic Article GET IT
Times cited: 219
Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS): baseline characteristics and comparison with USA population. Journal of cardiovascular risk. 2000 Academic Article GET IT
Times cited: 10
Case 3: Insulin-dependent diabetes mellitus. The American journal of cardiology. 2000 Conference Paper GET IT
A variant of p22(phox), involved in generation of reactive oxygen species in the vessel wall, is associated with progression of coronary atherosclerosis. Circulation research. 2000 Academic Article GET IT
Times cited: 130
Trends in plasma cholesterol levels in the atherosclerosis risk in communities (ARIC) study. Preventive medicine. 2000 Academic Article GET IT
Times cited: 29
Relation between baseline and on-treatment lipid parameters and first acute major coronary events in the Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS). Circulation. 2000 Academic Article GET IT
Times cited: 501
Case 2: a patient with low levels of high-density lipoprotein cholesterol. 2000 GET IT
Hydrolysis of phospholipids by purified milk lipoprotein lipase. Effect of apoprotein CII, CIII, A and E, and synthetic fragments. Clinica chimica acta; international journal of clinical chemistry. 2000 Academic Article GET IT
Times cited: 20
Transforming growth factor-beta1 (TGF-beta1) and TGF-beta2 decrease expression of CD36, the type B scavenger receptor, through mitogen-activated protein kinase phosphorylation of peroxisome proliferator-activated receptor-gamma. The Journal of biological chemistry. 2000 Academic Article GET IT
Times cited: 167
A prospective study of genetic markers of susceptibility to infection and inflammation, and the severity, progression, and regression of coronary atherosclerosis and its response to therapy. Journal of molecular medicine (Berlin, Germany). 2000 Academic Article GET IT
Times cited: 40
Case 1: a patient with elevated low-density lipoprotein cholesterol. The American journal of cardiology. 2000 Conference Paper GET IT
Times cited: 1
Interactions between angiotensin-I converting enzyme insertion/deletion polymorphism and response of plasma lipids and coronary atherosclerosis to treatment with fluvastatin: the lipoprotein and coronary atherosclerosis study. Journal of the American College of Cardiology. 2000 Academic Article GET IT
Times cited: 80
The evolving role of statins in the management of atherosclerosis. Journal of the American College of Cardiology. 2000 Review GET IT
Times cited: 552
Preventing coronary artery disease by lowering cholesterol levels: fifty years from bench to bedside. JAMA. 1999 Academic Article GET IT
Times cited: 150
Low HDL in Cardiovascular Disease. Proceedings of an EAS Workshop. Istanbul, Turkey, September 24-25, 1999. Abstracts. Atherosclerosis. 1999 Conference Paper GET IT
Lipid management in patients at moderate risk for coronary heart disease: insights from the Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS). The American journal of medicine. 1999 Academic Article GET IT
Times cited: 22
Three-dimensional structure of low density lipoproteins by electron cryomicroscopy. Proceedings of the National Academy of Sciences of the United States of America. 1999 Academic Article GET IT
Times cited: 117
Therapeutic impact of statin therapy in patients with low HDL cholesterol. Current atherosclerosis reports. 1999 Editorial Article GET IT
Lipid-lowering therapy for the primary prevention of coronary heart disease. Journal of the American College of Cardiology. 1999 Review GET IT
Times cited: 24
Lipoprotein lipase gene mutations, plasma lipid levels, progression/regression of coronary atherosclerosis, response to therapy, and future clinical events. Lipoproteins and Coronary Atherosclerosis Study. Atherosclerosis. 1999 Academic Article GET IT
Times cited: 32
Prognostic and therapeutic significance of low levels of high-density lipoprotein cholesterol: current perspectives. Archives of internal medicine. 1999 Editorial Article GET IT
Times cited: 8
Effect of moderate alcohol consumption on hypertriglyceridemia: a study in the fasting state. Archives of internal medicine. 1999 Academic Article GET IT
Times cited: 55
Correlation of serum triglyceride and its reduction by omega-3 fatty acids with lipid transfer activity and the neutral lipid compositions of high-density and low-density lipoproteins. Atherosclerosis. 1999 Academic Article GET IT
Times cited: 156
Lowering LDL cholesterol: questions from recent meta-analyses and subset analyses of clinical trial DataIssues from the Interdisciplinary Council on Reducing the Risk for Coronary Heart Disease, ninth Council meeting. Circulation. 1999 Conference Paper GET IT
Times cited: 95
Influence of low HDL on progression of coronary artery disease and response to fluvastatin therapy. Circulation. 1999 Academic Article GET IT
Times cited: 180
Impact of multiple risk factors on coronary artery disease: beyond total cholesterol. Introduction. The American journal of cardiology. 1998 Review GET IT
Triglyceride as a risk factor for coronary artery disease. The American journal of cardiology. 1998 Review GET IT
Times cited: 199
Citation classics in lipid measurement and applications. Clinical chemistry. 1998 Academic Article GET IT
Times cited: 1
Assessing the benefits of lipid-lowering therapy. The American journal of cardiology. 1998 Review GET IT
Times cited: 12
The Lipoprotein and Coronary Atherosclerosis Study (LCAS) in context: assessing the benefits of lipid-lowering therapy. Introduction. The American journal of cardiology. 1998 Academic Article GET IT
Times cited: 3
Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study. JAMA. 1998 Academic Article GET IT
Times cited: 5016
Consensus for the use of fibrates in the treatment of dyslipoproteinemia and coronary heart disease. Fibrate Consensus Group. The American journal of cardiology. 1998 Conference Paper GET IT
Times cited: 195
Triglyceride: the forgotten risk factor. Circulation. 1998 Editorial Article GET IT
Times cited: 110
Preventing coronary disease in women: brief observations from the clinical data. Journal of women's health. 1998 Academic Article GET IT
Times cited: 1
Risk factor modification: rationale for management of dyslipidemia. The American journal of medicine. 1998 Review GET IT
Long-term effects of low-density lipoprotein apheresis using an automated dextran sulfate cellulose adsorption system. Liposorber Study Group. The American journal of cardiology. 1998 Academic Article GET IT
Times cited: 101
The new cholesterol education imperative and some comments on niacin. The American journal of cardiology. 1998 Editorial Article GET IT
Times cited: 6
Cholesterol management in theory and practice. Circulation. 1997 Review GET IT
Times cited: 64
Circulating adhesion molecules VCAM-1, ICAM-1, and E-selectin in carotid atherosclerosis and incident coronary heart disease cases: the Atherosclerosis Risk In Communities (ARIC) study. Circulation. 1997 Academic Article GET IT
Times cited: 1261
Effects of lipid lowering therapy on progression of coronary and carotid artery disease. Current opinion in lipidology. 1997 Review GET IT
Times cited: 50
A new fluorometric method for measuring the action of C apolipoproteins on milk lipoprotein lipase. Clinica chimica acta; international journal of clinical chemistry. 1997 Academic Article GET IT
Times cited: 3
Design & rationale of the Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS). The American journal of cardiology. 1997 Academic Article GET IT
Times cited: 73
Effects of fluvastatin on coronary atherosclerosis in patients with mild to moderate cholesterol elevations (Lipoprotein and Coronary Atherosclerosis Study [LCAS]). The American journal of cardiology. 1997 Academic Article GET IT
Times cited: 317
Inhibitory effects of hypercholesterolemia and ox-LDL on angiogenesis-like endothelial growth in rabbit aortic explants. Essential role of basic fibroblast growth factor. Arteriosclerosis, thrombosis, and vascular biology. 1997 Academic Article GET IT
Times cited: 66
Stain therapy and reduced incidence of stroke. Implications of cholesterol-lowering therapy for cerebrovascular disease. Archives of internal medicine. 1997 Editorial Article GET IT
Times cited: 6
Results of recent large cholesterol-lowering trials and implications for clinical management. The American journal of cardiology. 1997 Editorial Article GET IT
Times cited: 27
Effective lowering of plasma, LDL, and esterified cholesterol in LDL receptor-knockout mice by adenovirus-mediated gene delivery of ApoB mRNA editing enzyme (Apobec1). Arteriosclerosis, thrombosis, and vascular biology. 1997 Academic Article GET IT
Times cited: 25
The Multiple Risk Factor Intervention Trial (MRFIT). A return to a landmark trial. JAMA. 1997 Comment GET IT
Times cited: 23
The case for aggressive lipid regulation. Hospital practice (1995). 1997 Review GET IT
Times cited: 3
Oxidative modifications of apoB-100 by exposure of low density lipoproteins to HOCL in vitro. Free radical biology & medicine. 1997 Academic Article GET IT
Times cited: 57
Effect of the apolipoprotein C-II/C-III1 ratio on the capacity of purified milk lipoprotein lipase to hydrolyse triglycerides in monolayer vesicles. Atherosclerosis. 1996 Academic Article GET IT
Times cited: 20
The Lipoprotein and Coronary Atherosclerosis Study (LCAS): design, methods, and baseline data of a trial of fluvastatin in patients without severe hypercholesterolemia. Controlled clinical trials. 1996 Academic Article GET IT
Times cited: 32
Choosing the right lipid-regulating agent. A guide to selection. Drugs. 1996 Review GET IT
Times cited: 46
Results of Lipid-Lowering Trials in the Elderly and a Look to the Future. The American journal of geriatric cardiology. 1996 Academic Article GET IT
Effects of gemfibrozil on very-low-density lipoprotein composition and low-density lipoprotein size in patients with hypertriglyceridemia or combined hyperlipidemia. Atherosclerosis. 1996 Academic Article GET IT
Times cited: 14
Apolipoprotein A-II influences the substrate properties of human HDL2 and HDL3 for hepatic lipase. Arteriosclerosis, thrombosis, and vascular biology. 1996 Academic Article GET IT
Times cited: 42
Effect of gemfibrozil on levels of lipoprotein[a] in type II hyperlipoproteinemic subjects. Journal of lipid research. 1996 Academic Article GET IT
Times cited: 25
Lipid lowering and coronary risk. Israel journal of medical sciences. 1996 Review GET IT
Times cited: 2
27th Bethesda Conference: matching the intensity of risk factor management with the hazard for coronary disease events. Task Force 1. Pathogenesis of coronary disease: the biologic role of risk factors. Journal of the American College of Cardiology. 1996 Review GET IT
Times cited: 103
Comparison of 2-year weight loss trends in behavioral treatments of obesity: diet, exercise, and combination interventions. Journal of the American Dietetic Association. 1996 Academic Article GET IT
Times cited: 183
Levels of soluble cell adhesion molecules in patients with dyslipidemia. Circulation. 1996 Academic Article GET IT
Times cited: 310
Cost of lipid-lowering statin drugs. The American journal of cardiology. 1996 Letter GET IT
Times cited: 3
Apolipoproteins: pathophysiology and clinical implications. Methods in enzymology. 1996 Review GET IT
Times cited: 14
Current and future therapeutic approaches to hyperlipidemia. Advances in pharmacology (San Diego, Calif.). 1996 Review GET IT
Times cited: 13
HMG-CoA reductase inhibitors: issues in assessing their benefits in coronary heart disease. Drug safety. 1996 Comment GET IT
Times cited: 1
Interaction of apolipoprotein[a] with apolipoproteinB-100 Cys3734 region in lipoprotein[a] is confirmed immunochemically. Journal of protein chemistry. 1996 Academic Article GET IT
Times cited: 14
Lipid-lowering trials: what have they taught us about morbidity and mortality?. Cardiology. 1996 Review GET IT
Times cited: 1
Lipid-regulating and antiatherosclerotic therapy: current options and future approaches. Cleveland Clinic journal of medicine. 1996 Review GET IT
Times cited: 5
Preventing heart attack and death in patients with coronary disease. Endorsed by the board of trustees of the American College of Cardiology. Cardio-vascular nursing. 1996 Conference Paper GET IT
Times cited: 4
Does post-menopausal hormone-replacement therapy increase risk for breast cancer? A perspective on the findings of the Nurses' Health Study. Pharmacological research. 1995 Academic Article GET IT
Times cited: 2
Effects of pravastatin in heart transplant recipients: implications of Kobashigawa et al. Current opinion in lipidology. 1995 Academic Article GET IT
Times cited: 4
Reduction of coronary events: evidence from clinical trials. Current opinion in lipidology. 1995 Editorial Article GET IT
Times cited: 1
Currently available hypolipidaemic drugs and future therapeutic developments. Bailliere's clinical endocrinology and metabolism. 1995 Review GET IT
Times cited: 38
ELISA quantitation of apolipoproteins in plasma lipoprotein fractions: ApoE in ApoB-containing lipoproteins (Lp B:E) and ApoB in ApoE-containing lipoproteins (Lp E:B). Journal of protein chemistry. 1995 Academic Article GET IT
Times cited: 4
Evidence that apoB-100 of low-density lipoproteins is a novel Src-related protein kinase. Journal of protein chemistry. 1995 Academic Article GET IT
Times cited: 7
Extending the benefit of lipid-regulating therapy to primary prevention. The American journal of cardiology. 1995 Review GET IT
Times cited: 4
Basic fibroblast growth factor reverses atherosclerotic impairment of human coronary angiogenesis-like responses in vitro. Atherosclerosis. 1995 Academic Article GET IT
Times cited: 14
Lipid lowering, regression, and coronary events. A review of the Interdisciplinary Council on Lipids and Cardiovascular Risk Intervention, Seventh Council meeting. Circulation. 1995 Conference Paper GET IT
Times cited: 83
Lipid risk factors and the regression of atherosclerosis. The American journal of cardiology. 1995 Review GET IT
Times cited: 14
AHA consensus panel statement. Preventing heart attack and death in patients with coronary disease. The Secondary Prevention Panel. 1995 GET IT
Times cited: 85
Preventing heart attack and death in patients with coronary disease. 1995 GET IT
Times cited: 303
Clinical investigations of the arrest and reversal of coronary artery disease. Coronary artery disease. 1995 Review GET IT
Times cited: 2
Relationship of the apolipoprotein E polymorphism with carotid artery atherosclerosis. American journal of human genetics. 1995 Academic Article GET IT
Times cited: 93
Hyperlipidemia: perspectives in diagnosis and treatment. Southern medical journal. 1995 Review GET IT
Times cited: 9
Plasma lipid transport in the hedgehog: partial characterization of structure and function of apolipoprotein A-I. Journal of lipid research. 1995 Academic Article GET IT
Times cited: 4
Thyroid hormone influences the maturation of apolipoprotein A-I messenger RNA in rat liver. The Journal of biological chemistry. 1995 Academic Article GET IT
Times cited: 17
High-density lipoprotein cholesterol, plasma triglyceride, and coronary heart disease: pathophysiology and management. Advances in pharmacology (San Diego, Calif.). 1995 Review GET IT
Times cited: 27
Adenovirus-mediated gene transfer of rat apolipoprotein B mRNA-editing protein in mice virtually eliminates apolipoprotein B-100 and normal low density lipoprotein production. The Journal of biological chemistry. 1994 Academic Article GET IT
Times cited: 93
Antihyperlipidaemic agents. Drug interactions of clinical significance. Drug safety. 1994 Review GET IT
Times cited: 54
Murine VCAM-1. Molecular cloning, mapping, and analysis of a truncated form. Journal of immunology (Baltimore, Md. : 1950). 1994 Academic Article GET IT
Times cited: 35
Structure of human apolipoprotein D: locations of the intermolecular and intramolecular disulfide links. Biochemistry. 1994 Academic Article GET IT
Times cited: 41
Immunoreactivity of apolipoprotein B-100 in oxidatively modified low density lipoprotein. Biological chemistry Hoppe-Seyler. 1994 Academic Article GET IT
Times cited: 7
Effects of beef and chicken consumption on plasma lipid levels in hypercholesterolemic men. Archives of internal medicine. 1994 Academic Article GET IT
Times cited: 45
Heart disease in the assessment and treatment of hypercholesterolemia: coronary artery disease and other atherosclerotic disease, family history, and left ventricular hypertrophy. The American journal of medicine. 1994 Review GET IT
Times cited: 8
Associations of allelic differences at the A-I/C-III/A-IV gene cluster with carotid artery intima-media thickness and plasma lipid transport in hypercholesterolemic-hypertriglyceridemic humans. Arteriosclerosis and thrombosis : a journal of vascular biology. 1994 Academic Article GET IT
Times cited: 30
Postmenopausal hormone-replacement therapy, plasma lipoprotein[a], and risk for coronary heart disease. The Journal of laboratory and clinical medicine. 1994 Editorial Article GET IT
Times cited: 11
Baseline characteristics of subjects in the Lipoprotein and Coronary Atherosclerosis Study (LCAS) with fluvastatin. The American journal of cardiology. 1994 Academic Article GET IT
Times cited: 16
Cholesterol levels in young adults: screen and intervene?. Hospital practice (Office ed.). 1994 Academic Article GET IT
Times cited: 1
No deception in symposium supplement. BMJ (Clinical research ed.). 1994 Letter GET IT
Prevention of coronary heart disease in 1994: evidence for intervention. Heart disease and stroke : a journal for primary care physicians. 1994 Review GET IT
Times cited: 5
Primary structure of apoB-100. Chemistry and physics of lipids. 1994 Academic Article GET IT
Times cited: 18
Recent advances in lipoprotein and atherosclerosis research at Baylor College of Medicine. Apolipoprotein B, lipoprotein[a], and transplantation arteriopathy. Texas Heart Institute journal. 1994 Review GET IT
Times cited: 5
Structure and orientation of apo B-100 peptides into a lipid bilayer. Journal of protein chemistry. 1994 Academic Article GET IT
Times cited: 11
The Second International Conference on Lipoprotein[a]: preface. Chemistry and physics of lipids. 1994 Conference Paper GET IT
Comparative effects of atenolol versus celiprolol on serum lipids and blood pressure in hyperlipidemic and hypertensive subjects. The American journal of cardiology. 1993 Academic Article GET IT
Times cited: 11
Cholesterol confusion in primary prevention of coronary artery disease. Cardiovascular drugs and therapy. 1993 Editorial Article GET IT
Times cited: 2
Does low cholesterol cause death?. Cardiovascular drugs and therapy. 1993 Editorial Article GET IT
Times cited: 10
Primary structure of Beijing duck apolipoprotein A-1. Journal of protein chemistry. 1993 Academic Article GET IT
Times cited: 7
Serum cholesterol. Doing the right thing. Circulation. 1993 Editorial Article GET IT
Times cited: 58
Human very low density lipoprotein structure: interaction of the C apolipoproteins with apolipoprotein B-100. Journal of lipid research. 1993 Academic Article GET IT
Times cited: 20
Plasma lipid, lipoprotein cholesterol, and apoprotein distributions in selected US communities. The Atherosclerosis Risk in Communities (ARIC) Study. Arteriosclerosis and thrombosis : a journal of vascular biology. 1993 Academic Article GET IT
Times cited: 190
Once-daily, extended-release gemfibrozil in patients with dyslipidemia. The Lopid SR Work Group I. The American journal of cardiology. 1993 Academic Article GET IT
Times cited: 14
Dyslipidemia and atherosclerosis. A forecast of pharmaceutical approaches. Circulation. 1993 Academic Article GET IT
Times cited: 17
Carbohydrate composition of protein and lipid components in sialic acid-rich and -poor low density lipoproteins from subjects with and without coronary artery disease. Journal of lipid research. 1993 Academic Article GET IT
Times cited: 65
Overview of current issues in management of dyslipidemia. The American journal of cardiology. 1993 Review GET IT
Times cited: 7
High density lipoprotein interconversions in rat and man as assessed with a novel nontransferable apolipopeptide. The Journal of biological chemistry. 1993 Academic Article GET IT
Times cited: 16
Multicenter evaluation of Reflotron direct dry-chemistry assay of high-density lipoprotein cholesterol in venous and fingerstick specimens. Clinical chemistry. 1993 Academic Article GET IT
Times cited: 11
Role of thyroid hormone in the expression of apolipoprotein A-IV and C-III genes in rat liver. Journal of lipid research. 1993 Academic Article GET IT
Times cited: 18
Does body fatness modify the effect of dietary cholesterol on serum cholesterol? Results from the Chicago Western Electric Study. American journal of epidemiology. 1993 Academic Article GET IT
Times cited: 18
Psychological profile of college students who use smokeless tobacco. Addictive behaviors. 1993 Academic Article GET IT
Times cited: 19
A symposium: triglycerides as a vascular risk factor: a global forum. Introduction. The American journal of cardiology. 1992 Academic Article GET IT
Times cited: 2
Hypertriglyceridemia: risks and perspectives. The American journal of cardiology. 1992 Review GET IT
Times cited: 36
Relation of triglyceride metabolism and coronary artery disease. Studies in the postprandial state. Arteriosclerosis and thrombosis : a journal of vascular biology. 1992 Academic Article GET IT
Times cited: 1114
Therapeutic intervention for hypercholesterolemia. Clinical cardiology. 1992 Review GET IT
Therapeutic intervention for hypercholesterolemia. Clinical cardiology. 1992 Academic Article GET IT
Times cited: 8
Transgenic mice expressing full-length human apolipoprotein B-100. Full-length human apolipoprotein B mRNA is essentially not edited in mouse intestine or liver. The Journal of biological chemistry. 1992 Academic Article GET IT
Times cited: 6
Treatment of refractory familial hypercholesterolemia by low-density lipoprotein apheresis using an automated dextran sulfate cellulose adsorption system. The Liposorber Study Group. The American journal of cardiology. 1992 Academic Article GET IT
Times cited: 93
Cholesterol consensus: a trans-Atlantic perspective. Amsterdam, The Netherlands, 31-October-1 November 1991. International journal of cardiology. 1992 Conference Paper GET IT
Times cited: 2
Different reactivities of high density lipoprotein2 subfractions with hepatic lipase. Journal of lipid research. 1992 Academic Article GET IT
Times cited: 77
Postprandial lipemia: reliability in an epidemiologic field study. American journal of epidemiology. 1992 Academic Article GET IT
Times cited: 25
Effect of sucrose diet on expression of apolipoprotein genes A-I, C-III and A-IV in rat liver. Atherosclerosis. 1992 Academic Article GET IT
Times cited: 12
Mouse macrophage receptor for acetylated low density lipoprotein: demonstration of a fully functional subunit in the membrane and with purified receptor. Proceedings of the National Academy of Sciences of the United States of America. 1992 Academic Article GET IT
Times cited: 13
Prevention of familial cardiovascular disease by screening for family history and lipids in youths. Clinical chemistry. 1992 Academic Article GET IT
Times cited: 13
More on SI units. The New England journal of medicine. 1992 Letter GET IT
Does body fatness modify the association between dietary cholesterol and risk of coronary death? Results from the Chicago Western Electric Study. Arteriosclerosis and thrombosis : a journal of vascular biology. 1992 Academic Article GET IT
Times cited: 12
The Lipid Research Clinics Coronary Primary Prevention Trial. Results of 6 years of post-trial follow-up. The Lipid Research Clinics Investigators. Archives of internal medicine. 1992 Academic Article GET IT
Times cited: 73
Sialic acid content of human low density lipoproteins affects their interaction with cell receptors and intracellular lipid accumulation. Journal of lipid research. 1992 Academic Article GET IT
Times cited: 79
Hyperlipidemia after heart transplantation: report of a 6-year experience, with treatment recommendations. Journal of the American College of Cardiology. 1992 Academic Article GET IT
Times cited: 121
Apolipoprotein E: phospholipid binding studies with synthetic peptides from the carboxyl terminus. Biochemistry. 1992 Academic Article GET IT
Times cited: 42
Plasma lipid transport in the preruminant calf, Bos spp: primary structure of bovine apolipoprotein A-I. Biochimica et biophysica acta. 1992 Academic Article GET IT
Times cited: 12
Comparative effects of simvastatin and lovastatin in patients with hypercholesterolemia. The Simvastatin and Lovastatin Multicenter Study Participants. Clinical therapeutics. 1992 Academic Article GET IT
Times cited: 42
Effect of FK 506 and cyclosporine on plasma cholesterol levels in rabbits. Transplantation proceedings. 1991 Academic Article GET IT
Times cited: 6
Michael E. DeBakey. Clinical cardiology. 1991 Academic Article GET IT
Role of apolipoprotein E and B gene variation in determining response of lipid, lipoprotein, and apolipoprotein levels to increased dietary cholesterol. American journal of human genetics. 1991 Academic Article GET IT
Times cited: 72
Locating a low density lipoprotein-targeting domain of human apolipoprotein B-100 by expressing a minigene construct in transgenic mice. The Journal of biological chemistry. 1991 Academic Article GET IT
Times cited: 9
Lipoprotein(a) and apolipoprotein changes after cardiac transplantation. Journal of the American College of Cardiology. 1991 Academic Article GET IT
Times cited: 37
Ten weeks of intermittent hypocalcemic stimulation does not produce functional parathyroid hyperplasia. The American journal of the medical sciences. 1991 Academic Article GET IT
Times cited: 3
Influence of short term dietary cholesterol and fat on human plasma Lp[a] and LDL levels. Journal of lipid research. 1991 Academic Article GET IT
Times cited: 60
Hypercholesterolemia: new findings and clinical applications. Introduction. The American journal of medicine. 1991 Academic Article GET IT
Rationale for treatment. 1991 GET IT
Times cited: 3
Management of hypertriglyceridemic patients. A. Treatment classifications and goals. The American journal of cardiology. 1991 Review GET IT
Times cited: 23
Postprandial hyperlipidemia. The American journal of cardiology. 1991 Review GET IT
Times cited: 16
The hypertriglyceridemias: risk and management. Introduction. The American journal of cardiology. 1991 Review GET IT
Times cited: 13
An economic evaluation of lovastatin for cholesterol lowering and coronary artery disease reduction. The American journal of cardiology. 1991 Academic Article GET IT
Times cited: 70
Cholesterol metabolism in hypercholesterolemia-resistant rabbits. Atherosclerosis. 1991 Academic Article GET IT
Times cited: 12
Cholesterol intake and serum cholesterol level. The New England journal of medicine. 1991 Editorial Article GET IT
Times cited: 16
No severe bottleneck during human evolution: evidence from two apolipoprotein C-II deficiency alleles. American journal of human genetics. 1991 Academic Article GET IT
Times cited: 34
Enhanced hepatic uptake and processing of cholesterol esters from low density lipoprotein by specific lactosaminated Fab fragments. Arteriosclerosis and thrombosis : a journal of vascular biology. 1991 Academic Article GET IT
Times cited: 7
Calcium channel blockers and the prevention of atherosclerosis. American journal of hypertension. 1990 Review GET IT
Times cited: 9
Dietary cholesterol absorption, and sterol and bile acid excretion in hypercholesterolemia-resistant white rabbits. Journal of lipid research. 1990 Academic Article GET IT
Times cited: 29
A symposium: The significance of high-density lipoprotein cholesterol in the prevention of coronary artery disease. September 8-10, 1989, Phoenix, Arizona. The American journal of cardiology. 1990 Academic Article GET IT
Interrelationship of triglycerides with lipoproteins and high-density lipoproteins. The American journal of cardiology. 1990 Review GET IT
Times cited: 37
Cyclopentanoid analogs of dipalmitoyl phosphatidic acid: effect of backbone geometry on thermotropic properties. Chemistry and physics of lipids. 1990 Academic Article GET IT
Times cited: 8
Effect of blood collection and processing on radioimmunoassay results for apolipoprotein B in plasma. Clinical chemistry. 1990 Academic Article GET IT
Times cited: 24
Isolation and characterization of sulfhydryl and disulfide peptides of human apolipoprotein B-100. Proceedings of the National Academy of Sciences of the United States of America. 1990 Academic Article GET IT
Times cited: 84
Tangier disease in a black patient: an unusual clinical presentation. 1990 GET IT
Times cited: 5
Cholesterol metabolism in fibroblasts from rabbits resistant to diet-induced hypercholesterolemia. Journal of lipid research. 1990 Academic Article GET IT
Times cited: 6
Lipid hydroperoxy and hydroxy derivatives in copper-catalyzed oxidation of low density lipoprotein. Journal of lipid research. 1990 Academic Article GET IT
Times cited: 127
Development of cholesterol homeostatic memory in the rat is influenced by maternal diets. Metabolism: clinical and experimental. 1990 Academic Article GET IT
Times cited: 38
Identification of a detergent-solubilized plasma membrane protein from rat liver recognizing apolipoprotein A-IV. Biochimica et biophysica acta. 1990 Academic Article GET IT
Times cited: 1
The cholesterol facts. A summary of the evidence relating dietary fats, serum cholesterol, and coronary heart disease. A joint statement by the American Heart Association and the National Heart, Lung, and Blood Institute. The Task Force on Cholesterol Issues, American Heart Association. Circulation. 1990 Review GET IT
Times cited: 532
Role of thyroid hormones in apolipoprotein A-I gene expression in rat liver. The Journal of clinical investigation. 1990 Academic Article GET IT
Times cited: 42
[Children and dyslipemia]. Revista clinica espanola. 1990 Review GET IT
Medical costs of coronary artery disease in the United States. The American journal of cardiology. 1990 Academic Article GET IT
Times cited: 92
Analysis of the carbohydrate composition of glycoproteins by high-performance liquid chromatography. Journal of protein chemistry. 1990 Academic Article GET IT
Times cited: 14
Determination of cysteine on low-density lipoproteins using the fluorescent probe, 5-iodoacetamidofluoresceine. Biochimica et biophysica acta. 1990 Academic Article GET IT
Times cited: 27
Apolipoproteins and metabolism in atherosclerosis. Transactions of the American Clinical and Climatological Association. 1990 Review GET IT
Times cited: 4
Blood cholesterol screening in several environments using a portable, dry-chemistry analyzer and fingerstick blood samples. Lipid Research Clinics Cholesterol Screening Study Group. The American journal of cardiology. 1990 Academic Article GET IT
Times cited: 17
Effect of alcohol dose on plasma lipoprotein subfractions and lipolytic enzyme activity in active and inactive men. Metabolism: clinical and experimental. 1990 Academic Article GET IT
Times cited: 64
Structure and conformational analysis of lipid-associating peptides of apolipoprotein B-100 produced by trypsinolysis. Journal of protein chemistry. 1989 Academic Article GET IT
Times cited: 19
Kinetics of tryptic hydrolysis as a probe of the structure of human plasma apolipoprotein A-II. Biochimica et biophysica acta. 1989 Academic Article GET IT
Times cited: 8
Metabolism of apolipoprotein A-IV in rat. Biochimica et biophysica acta. 1989 Academic Article GET IT
Times cited: 7
The effect of triphasic oral contraceptives on plasma lipids and lipoproteins. American journal of obstetrics and gynecology. 1989 Academic Article GET IT
Times cited: 29
Structure of bovine milk lipoprotein lipase. The Journal of biological chemistry. 1989 Academic Article GET IT
Times cited: 42
[Women and ischemic cardiopathy]. Revista clinica espanola. 1989 Review GET IT
Times cited: 2
Accuracy and precision of analyses for total cholesterol as measured with the Reflotron cholesterol method. Clinical chemistry. 1989 Academic Article GET IT
Times cited: 22
Effects of cyclosporine therapy on plasma lipoprotein levels. JAMA. 1989 Academic Article GET IT
Times cited: 261
The hyperlipoproteinemias. The Medical clinics of North America. 1989 Review GET IT
Times cited: 15
Rapid modulation of rat adipocyte lipoprotein lipase: effect of calcium, A23187 ionophore, and thrombin. Biochimica et biophysica acta. 1989 Academic Article GET IT
Times cited: 8
Effect of triglyceride levels on methyl and methylene envelope line widths in proton nuclear magnetic resonance spectroscopy of human plasma. The New England journal of medicine. 1989 Academic Article GET IT
Times cited: 22
[HDL cholesterol profile in 1988]. Revista clinica espanola. 1989 Review GET IT
The primary structure of human apolipoprotein A-IV. Biochimica et biophysica acta. 1989 Academic Article GET IT
Times cited: 21
A dual-precipitation method evaluated for measurement of cholesterol in high-density lipoprotein subfractions HDL2 and HDL3 in human plasma. Clinical chemistry. 1989 Academic Article GET IT
Times cited: 86
Development and partial metabolic characterization of a dietary cholesterol-resistant colony of rabbits. Journal of lipid research. 1989 Academic Article GET IT
Times cited: 26
Diet and cholesterol guidelines and coronary heart disease. Journal of the American College of Cardiology. 1989 Academic Article GET IT
Times cited: 5
Effect of sucrose diet on apolipoprotein biosynthesis in rat liver. Increase in apolipoprotein E gene transcription. The Journal of biological chemistry. 1989 Academic Article GET IT
Times cited: 45
Structure of apolipoprotein B-100 of human low density lipoproteins. Arteriosclerosis (Dallas, Tex.). 1989 Academic Article GET IT
Times cited: 160
Treatment of symptomatic peripheral atherosclerotic disease with a rotational atherectomy device. The American journal of cardiology. 1989 Academic Article GET IT
Times cited: 51
[Non-pharmacologic treatment of hyperlipemia: diet and exercise]. Revista clinica espanola. 1989 Review GET IT
[Detection and treatment of lipid disorders]. 1988 GET IT
Kinetics and mechanism of transfer of synthetic model apolipoproteins. Biochemistry. 1988 Academic Article GET IT
Times cited: 6
Health family trees: a tool for finding and helping young family members of coronary and cancer prone pedigrees in Texas and Utah. American journal of public health. 1988 Academic Article GET IT
Times cited: 67
A multicenter comparison of lovastatin and cholestyramine therapy for severe primary hypercholesterolemia. The Lovastatin Study Group III. JAMA. 1988 Academic Article GET IT
Times cited: 124
Primary sequence mapping of human apolipoprotein B-100 epitopes. Comparisons of trypsin accessibility and immunoreactivity and implication for apoB conformation. European journal of biochemistry. 1988 Academic Article GET IT
Times cited: 8
Lipoprotein metabolism and the etiology of hyperlipidemia. Hospital practice (Office ed.). 1988 Review GET IT
Times cited: 13
Effect of blood collection and processing on radioimmunoassay results for apolipoprotein A-I in plasma. Clinical chemistry. 1988 Academic Article GET IT
Times cited: 23
The recognition and management of hyperlipidaemia in adults: A policy statement of the European Atherosclerosis Society. 1988 GET IT
Times cited: 269
Two-year follow-up of patients treated with a very-low-calorie diet and exercise training. Journal of the American Dietetic Association. 1988 Academic Article GET IT
Times cited: 55
Lactosaminated Fab fragments specific for low density lipoproteins/hepatocyte targeting and hypolipoproteinemic activity. Arteriosclerosis (Dallas, Tex.). 1988 Academic Article GET IT
Times cited: 2
The lipid hypothesis. Beitrage zur Infusionstherapie = Contributions to infusion therapy. 1988 Review GET IT
Human apolipoprotein B: analysis of internal repeats and homology with other apolipoproteins. Journal of lipid research. 1987 Academic Article GET IT
Times cited: 50
A complex Hind III polymorphism in the human apolipoprotein-B gene (APOB). Nucleic acids research. 1987 Academic Article GET IT
Times cited: 2
Apolipoprotein B-48 is the product of a messenger RNA with an organ-specific in-frame stop codon. Science (New York, N.Y.). 1987 Academic Article GET IT
Times cited: 537
Monoclonal antibodies as probes of high-density lipoprotein structure: identification and localization of a lipid-dependent epitope. Biochemistry. 1987 Academic Article GET IT
Times cited: 7
High density lipoprotein2. Relationship of the plasma levels of this lipoprotein species to its composition, to the magnitude of postprandial lipemia, and to the activities of lipoprotein lipase and hepatic lipase. The Journal of clinical investigation. 1987 Academic Article GET IT
Times cited: 330
Hyperlipidemia following heart transplantation: natural history and intervention with mevinolin (lovastatin). Transplantation proceedings. 1987 Academic Article GET IT
Times cited: 36
Lecithin:cholesterol acyltransferase. Functional regions and a structural model of the enzyme. The Journal of biological chemistry. 1987 Academic Article GET IT
Times cited: 76
Rationale for diphosphonate therapy in hypercalcemia of malignancy. Introduction. The American journal of medicine. 1987 Academic Article GET IT
Times cited: 12
Apolipoprotein A-IV. A determinant for binding and uptake of high density lipoproteins by rat hepatocytes. The Journal of biological chemistry. 1986 Academic Article GET IT
Times cited: 111
Radioimmunoassay of rat apolipoprotein A-IV. Analytical biochemistry. 1986 Academic Article GET IT
Times cited: 1
Determination of the molecular mass of apolipoprotein B-100. A chemical approach. The Biochemical journal. 1986 Academic Article GET IT
Times cited: 8
The primary structure of apolipoprotein A-I from rabbit high-density lipoprotein. European journal of biochemistry. 1986 Academic Article GET IT
Times cited: 18
The complete cDNA and amino acid sequence of human apolipoprotein B-100. The Journal of biological chemistry. 1986 Academic Article GET IT
Times cited: 155
Association of levels of lipoprotein Lp(a), plasma lipids, and other lipoproteins with coronary artery disease documented by angiography. Circulation. 1986 Academic Article GET IT
Times cited: 823
Apolipoprotein E-mediated binding of hypertriglyceridemic very low density lipoproteins to isolated low density lipoprotein receptors detected by ligand blotting. Biochemical and biophysical research communications. 1986 Academic Article GET IT
Times cited: 17
Binding of apoA-IV-phospholipid complexes to plasma membranes of rat liver. Biochemical and biophysical research communications. 1986 Academic Article GET IT
Times cited: 20
The helical hydrophobic moment avoids prolines in phospholipid-binding proteins. Biochemical and biophysical research communications. 1986 Academic Article GET IT
Times cited: 7
Plasma metabolism of apolipoprotein A-IV in humans. Journal of lipid research. 1986 Academic Article GET IT
Times cited: 62
Effects of insulin on lipoprotein secretion in rat hepatocyte cultures. The role of the insulin receptor. The Journal of biological chemistry. 1986 Academic Article GET IT
Times cited: 53
Enhanced catabolism of low density lipoproteins in rat by lactosaminated Fab fragment. A new carrier of macromolecules to the liver. The Journal of biological chemistry. 1986 Academic Article GET IT
Times cited: 9
Lipid-peptide association and activation of lecithin:cholesterol acyltransferase. Effect of alpha-helicity. The Journal of biological chemistry. 1986 Academic Article GET IT
Times cited: 29
Effect of alcohol intake and exercise on plasma high-density lipoprotein cholesterol subfractions and apolipoprotein A-I in women. The American journal of cardiology. 1986 Academic Article GET IT
Times cited: 29
Diet, nutrition, and heart disease. Journal of the American Dietetic Association. 1986 Academic Article GET IT
Times cited: 6
Treatment of hyperlipidemia. The American journal of cardiology. 1986 Review GET IT
Times cited: 10
Plasma catabolism of human apolipoprotein E isoproteins: lack of conversion of the doubly sialylated form to the asialo form in plasma. Metabolism: clinical and experimental. 1986 Academic Article GET IT
Times cited: 9
The diagnosis and management of hyperlipidemia. Disease-a-month : DM. 1986 Review GET IT
Times cited: 10
Soup consumption as a behavioral weight loss strategy. Journal of the American Dietetic Association. 1986 Academic Article GET IT
Times cited: 13
Interactions of the major risk factors for coronary heart disease. The American journal of medicine. 1986 Academic Article GET IT
Times cited: 42
In vivo interaction of synthetic acylated apopeptides with high density lipoproteins in rat. The Journal of clinical investigation. 1986 Academic Article GET IT
Times cited: 12
Digital imaging fluorescence microscopy. Methods in enzymology. 1986 Academic Article GET IT
Times cited: 9
Introduction to the plasma lipoproteins. Methods in enzymology. 1986 Review GET IT
Times cited: 286
Isolation and assay of the Ac-LDL receptor. Methods in enzymology. 1986 Academic Article GET IT
Times cited: 8
Partially reassembled high density lipoproteins. Effects on cholesterol flux, synthesis, and esterification in normal human skin fibroblasts. Arteriosclerosis (Dallas, Tex.). 1986 Academic Article GET IT
Times cited: 33
Abnormal interaction of the human apolipoprotein A-I variant [Lys107----0] with high density lipoproteins. Biochemical and biophysical research communications. 1985 Academic Article GET IT
Times cited: 6
Origin of apolipoprotein A-I polymorphism in plasma. The Journal of biological chemistry. 1985 Academic Article GET IT
Times cited: 43
Isolation and characterization of the human apolipoprotein A-II gene. Electron microscopic analysis of RNA:DNA hybrids, nucleotide sequence, identification of a polymorphic MspI site, and general structural organization of apolipoprotein genes. The Journal of biological chemistry. 1985 Academic Article GET IT
Times cited: 30
The structure of the human apolipoprotein C-II gene. Electron microscopic analysis of RNA:DNA hybrids, complete nucleotide sequence, and identification of 5' homologous sequences among apolipoprotein genes. The Journal of biological chemistry. 1985 Academic Article GET IT
Times cited: 52
Lateral distribution of phospholipid and cholesterol in apolipoprotein A-I recombinants. Biochemistry. 1985 Academic Article GET IT
Times cited: 32
The human apolipoprotein B-100 gene: a highly polymorphic gene that maps to the short arm of chromosome 2. Biochemical and biophysical research communications. 1985 Academic Article GET IT
Times cited: 35
Apolipoprotein E: phospholipid binding studies with synthetic peptides containing the putative receptor binding region. Biochemistry. 1985 Academic Article GET IT
Times cited: 18
Molecular cloning and expression of partial cDNAs and deduced amino acid sequence of a carboxyl-terminal fragment of human apolipoprotein B-100. Proceedings of the National Academy of Sciences of the United States of America. 1985 Academic Article GET IT
Times cited: 36
Spontaneous and plasma factor-mediated transfer of pyrenyl cerebrosides between model and native lipoproteins. Biochimica et biophysica acta. 1985 Academic Article GET IT
Times cited: 16
Plasma lipid and lipoprotein response of humans to beef fat, coconut oil and safflower oil. The American journal of clinical nutrition. 1985 Academic Article GET IT
Times cited: 68
Some reflections on arteriosclerosis: past, present, and future. Circulation. 1985 Academic Article GET IT
Times cited: 12
Murine macrophage tumors are a source of a 260,000-dalton acetyl-low density lipoprotein receptor. The Journal of biological chemistry. 1985 Academic Article GET IT
Times cited: 49
Fluorescence assay of the specificity of human plasma and bovine liver phospholipid transfer proteins. Biochimica et biophysica acta. 1985 Academic Article GET IT
Times cited: 30
Digital imaging fluorescence microscopy: spatial heterogeneity of photobleaching rate constants in individual cells. The Journal of cell biology. 1985 Academic Article GET IT
Times cited: 133
Human liver fatty acid binding protein cDNA and amino acid sequence. Functional and evolutionary implications. The Journal of biological chemistry. 1985 Academic Article GET IT
Times cited: 84
Metabolism of normal and modified low-density lipoproteins by macrophage cell lines of murine and human origin. Biochimica et biophysica acta. 1985 Academic Article GET IT
Times cited: 66
Identification of peptides containing tryptophan, tyrosine, and phenylalanine using photodiode-array spectrophotometry. Analytical biochemistry. 1985 Academic Article GET IT
Times cited: 27
Proapolipoprotein A-I conversion kinetics in vivo in human and in rat. Proceedings of the National Academy of Sciences of the United States of America. 1985 Academic Article GET IT
Times cited: 11
Monoclonal antibodies against bovine milk lipoprotein lipase. Characterization of an antibody specific for the apolipoprotein C-II binding site. The Journal of biological chemistry. 1985 Academic Article GET IT
Times cited: 17
Conformational properties of human and rat apolipoprotein A-IV. Journal of lipid research. 1985 Academic Article GET IT
Times cited: 11
Expression of LDL receptor binding determinants in very low density lipoproteins. Annals of the New York Academy of Sciences. 1985 Review GET IT
Times cited: 3
Hypertriglyceridemia: lipoprotein receptors and atherosclerosis. Advances in experimental medicine and biology. 1985 Academic Article GET IT
Times cited: 15
Relationship of plasma lipoprotein Lp(a) levels to race and to apolipoprotein B. Arteriosclerosis (Dallas, Tex.). 1985 Academic Article GET IT
Times cited: 224
The role of hydrophobicity in the structure of the human plasma lipoproteins. Advances in experimental medicine and biology. 1985 Academic Article GET IT
Low-density lipoprotein receptor binding determinants switch from apolipoprotein E to apolipoprotein B during conversion of hypertriglyceridemic very-low-density lipoprotein to low-density lipoproteins. The Journal of biological chemistry. 1984 Academic Article GET IT
Times cited: 97
Diet and health. The Western journal of medicine. 1984 Academic Article GET IT
Times cited: 2
Metabolism of apolipoprotein B in large triglyceride-rich very low density lipoproteins of normal and hypertriglyceridemic subjects. The Journal of clinical investigation. 1984 Academic Article GET IT
Times cited: 183
Postprandial lipemia. A key for the conversion of high density lipoprotein2 into high density lipoprotein3 by hepatic lipase. The Journal of clinical investigation. 1984 Academic Article GET IT
Times cited: 208
Directions of atherosclerosis research in the 1980s and 1990s. Circulation. 1984 Academic Article GET IT
Times cited: 6
In vitro binding of synthetic acylated lipid-associating peptides to high-density lipoproteins: effect of hydrophobicity. Biochemistry. 1984 Academic Article GET IT
Times cited: 21
Measurement and prediction of the rates of spontaneous transfer of phospholipids between plasma lipoproteins. Biochimica et biophysica acta. 1984 Academic Article GET IT
Times cited: 73
Apolipoprotein C-II deficiency revisited. The New England journal of medicine. 1984 Editorial Article GET IT
Times cited: 5
Thermodynamics of lipid-protein association. Enthalphy of association of apolipoprotein A-II with dimyristoylphosphatidylcholine-cholesterol mixtures. Biochimica et biophysica acta. 1984 Academic Article GET IT
Times cited: 12
Coronaries and diet. Nature. 1984 Letter GET IT
Recommendations for treatment of hyperlipidemia in adults. A joint statement of the Nutrition Committee and the Council on Arteriocslerosis. Circulation. 1984 Academic Article GET IT
Times cited: 121
In vitro transfer of phosphatidylcholines and their ether analogs by a human and rat plasma exchange factor. Biochemical and biophysical research communications. 1984 Academic Article GET IT
Times cited: 3
Chelation therapy in 1984. Texas medicine. 1984 Academic Article GET IT
Times cited: 2
Linking biomedical research to prevention in the community. Health values. 1984 Academic Article GET IT
Recommendations for the treatment of hyperlipidemia in adults. A joint statement of the Nutrition Committee and the Council on Arteriosclerosis of the American Heart Association. Arteriosclerosis (Dallas, Tex.). 1984 Academic Article GET IT
Times cited: 55
Identification of proapoa-I in rat lymph and plasma: metabolic conversion to "mature" apoA-I. Biochemical and biophysical research communications. 1983 Academic Article GET IT
Times cited: 10
High-density lipoproteins: biochemical and metabolic factors. The American journal of cardiology. 1983 Academic Article GET IT
Times cited: 13
Effects of a low cholesterol eating plan on plasma lipids: results of a three-year community study. American journal of public health. 1983 Academic Article GET IT
Times cited: 26
Esterase-type of activity possessed by human plasma apolipoprotein C-II and its synthetic fragments. Chemistry and physics of lipids. 1983 Academic Article GET IT
Times cited: 12
Clinical diagnosis of hyperlipoproteinemia. The American journal of medicine. 1983 Academic Article GET IT
Times cited: 5
Action of lipoprotein lipase on mixed triacylglycerol/phosphatidylcholine monolayers. Activation by apolipoprotein C-II. The Journal of biological chemistry. 1983 Academic Article GET IT
Times cited: 38
Action of lipoprotein lipase on phospholipid monolayers. Activation by apolipoprotein C-II. Biochemistry. 1983 Academic Article GET IT
Times cited: 48
Apolipoprotein E mediates uptake of Sf 100-400 hypertriglyceridemic very low density lipoproteins by the low density lipoprotein receptor pathway in normal human fibroblasts. The Journal of biological chemistry. 1983 Academic Article GET IT
Times cited: 88
Human plasma lipoprotein [a]. Structural properties. The Journal of biological chemistry. 1983 Academic Article GET IT
Times cited: 337
Interaction of synthetic N-5-dimethylaminonaphthalene-1-sulfonyl-apolipoprotein C-II peptides with lipoprotein lipase. The Journal of biological chemistry. 1983 Academic Article GET IT
Times cited: 20
A simplified approach to resonance energy transfer in membranes, lipoproteins and spatially restricted systems. Biophysical chemistry. 1983 Academic Article GET IT
Times cited: 25
Inverse relationship between blood levels of high density lipoprotein subfraction 2 and magnitude of postprandial lipemia. Proceedings of the National Academy of Sciences of the United States of America. 1983 Academic Article GET IT
Times cited: 321
Effect of alcohol intake on high-density lipoprotein cholesterol levels in runners and inactive men. JAMA. 1983 Academic Article GET IT
Times cited: 72
Effects of stress management training and dietary changes in treating ischemic heart disease. JAMA. 1983 Academic Article GET IT
Times cited: 167
Effect of cholesterol feeding on the distribution of plasma lipoproteins and on the metabolism of apolipoprotein E in the rabbit. Journal of lipid research. 1983 Academic Article GET IT
Times cited: 47
The application of an improved solid phase synthetic technique to the delineation of an antigenic site of apolipoprotein A-II. Peptides. 1983 Academic Article GET IT
Times cited: 8
The transport of plasma lipids: basic and clinical research and relationship to coronary heart disease. Cardiovascular Research Center bulletin. 1983 Academic Article GET IT
Times cited: 1
Workshop on apolipoprotein quantification. Arteriosclerosis (Dallas, Tex.). 1983 Academic Article GET IT
Times cited: 11
Apolipoprotein-E degradation in human very low density lipoproteins by plasma protease(s): chemical and biological consequences. Biochemical and biophysical research communications. 1982 Academic Article GET IT
Times cited: 38
Action of lecithin:cholesterol acyltransferase on model lipoproteins. Preparation and characterization of model nascent high density lipoprotein. Biochimica et biophysica acta. 1982 Academic Article GET IT
Times cited: 41
Occupational screenings: recruitment from private industry. Circulation. 1982 Academic Article GET IT
Times cited: 5
Co-clustering and internalization of low-density lipoproteins and alpha 2-macroglobulin in human skin fibroblasts. Experimental cell research. 1982 Academic Article GET IT
Times cited: 24
Receptor-mediated uptake of hypertriglyceridemic very low density lipoproteins by normal human fibroblasts. Journal of lipid research. 1982 Academic Article GET IT
Times cited: 66
Kinetics and mechanism of the spontaneous transfer of fluorescent phosphatidylcholines between apolipoprotein-phospholipid recombinants. Biochemistry. 1982 Academic Article GET IT
Times cited: 94
Kinetics of spontaneous and plasma-stimulated sphingomyelin transfer. Biochimica et biophysica acta. 1982 Academic Article GET IT
Times cited: 35
Hypertriglyceridemic very low density lipoproteins induce triglyceride synthesis and accumulation in mouse peritoneal macrophages. The Journal of clinical investigation. 1982 Academic Article GET IT
Times cited: 137
Kinetics and mechanism of the spontaneous transfer of fluorescent phospholipids between apolipoprotein-phospholipid recombinants. Effect of the polar headgroup. The Journal of biological chemistry. 1982 Academic Article GET IT
Times cited: 61
Cholesteryl ester-rich microemulsions: stable protein-free analogs of low density lipoproteins. Journal of lipid research. 1982 Academic Article GET IT
Times cited: 22
Evaluating commercial weight-loss clinics. Archives of internal medicine. 1982 Academic Article GET IT
Times cited: 5
Effect on saturated and unsaturated fat diets on lipid profiles of plasma lipoproteins. Atherosclerosis. 1982 Academic Article GET IT
Times cited: 23
Incorporation of defined cholesteryl esters into lipoproteins using cholesteryl ester-rich microemulsions. The Journal of biological chemistry. 1982 Academic Article GET IT
Times cited: 38
5-(dimethylamino)naphthalene-1-sulfonic acid, a fluorescent probe of the medium chain fatty acid binding site of serum albumin. Biochemistry. 1982 Academic Article GET IT
Times cited: 8
Apolipoprotein/lipid interactions: studies with synthetic polypeptides. CRC critical reviews in biochemistry. 1982 Review GET IT
Times cited: 62
Lipoprotein Lipase Interaction with Synthetic N-Dansyl Fragments of Apolipoprotein C-II. Biophysical journal. 1982 Academic Article GET IT
Times cited: 19
The high density lipoproteins. Exposes annuels de biochimie medicale. 1982 Review GET IT
Thermodynamics of lipid-protein association in human plasma lipoproteins. Biophysical journal. 1982 Academic Article GET IT
Times cited: 3
Reassembled model lipoproteins. Lipid dynamics in recombinants of human apolipoprotein A-II and dimyristoylphosphatidylcholine. The Journal of biological chemistry. 1981 Academic Article GET IT
Times cited: 16
Effect of saturated and unsaturated fat diets on molecular species of phosphatidylcholine and sphingomyelin of human plasma lipoproteins. Biochimica et biophysica acta. 1981 Academic Article GET IT
Times cited: 38
Thermodynamics of lipid-protein association. The free energy of association of lecithin with reduced and carboxymethylated apolipoprotein A-II from human plasma high density lipoprotein. The Journal of biological chemistry. 1981 Academic Article GET IT
Times cited: 28
Human smooth muscle cells cultured from atherosclerotic plaques and uninvolved vessel wall. In vitro. 1981 Academic Article GET IT
Times cited: 11
Thermodynamics of lipid--protein associations: the enthalpy of binding of Apo C-III to synthetic phosphatidylcholines. Canadian journal of biochemistry. 1981 Academic Article GET IT
Times cited: 9
Limitations of behavioral treatment of obesity: review and analysis. Journal of behavioral medicine. 1981 Academic Article GET IT
Times cited: 74
Low density lipoproteins reconstituted with steroids containing the nitrobenzoxadiazole fluorophore. Journal of lipid research. 1981 Academic Article GET IT
Times cited: 47
Regression of atherosclerosis. The American journal of medicine. 1981 Editorial Article GET IT
Times cited: 14
Separation of the apoprotein components of human very low density lipoproteins by ion-paired, reversed-phase high performance liquid chromatography. Lipids. 1981 Academic Article GET IT
Times cited: 18
Human plasma high density apolipoprotein A-I: effect of protein-protein interactions on the spontaneous formation of a lipid-protein recombinant. Biochemical and biophysical research communications. 1981 Academic Article GET IT
Times cited: 17
Mechanism of lipid-protein interaction in the plasma lipoproteins: identification of a lipid-binding site in apolipoprotein A-II. Biochemistry. 1981 Academic Article GET IT
Times cited: 22
Physical properties of lipid-protein complexes formed by the interaction of dimyristoylphosphatidylcholine and human high-density apolipoprotein A-II. Biochemistry. 1981 Academic Article GET IT
Times cited: 29
Thermodynamics of lipid-protein interactions: Interaction of apolipoprotein A-II from human plasma high-density lipoproteins with dimyristoylphosphatidylcholine. Biochemistry. 1981 Academic Article GET IT
Times cited: 54
Diet and coronary heart disease: the statistical analysis of risk. Circulation. 1981 Editorial Article GET IT
Times cited: 4
Effect of exercise training on plasma high-density lipoprotein cholesterol in coronary disease patients. American heart journal. 1981 Academic Article GET IT
Times cited: 57
Oxandrolone and plasma triglyceride reduction: effect on triglyceride-rich and high density lipoproteins. Artery. 1981 Academic Article GET IT
Times cited: 4
Relationship of hypertriglyceridemia to atherosclerosis. Arteriosclerosis (Dallas, Tex.). 1981 Academic Article GET IT
Times cited: 68
Dynamics of lipid-protein interactions. Interaction of apolipoprotein A-II from human plasma high density lipoproteins with dimyristoylphosphatidylcholine. The Journal of biological chemistry. 1980 Academic Article GET IT
Times cited: 14
Influence of an atherogenic diet on the structure of swine low density lipoproteins. Journal of lipid research. 1980 Academic Article GET IT
Times cited: 20
Magnetic resonance studies of apolipoprotein C-I nitroxide labeled or [13C]methyl enriched at methionine-38. Biochemistry. 1980 Academic Article GET IT
Times cited: 12
The conformational properties of human plasma apolipoprotein C-II. A spectroscopic study. The Journal of biological chemistry. 1980 Academic Article GET IT
Times cited: 47
Lipoprotein-X: carbon-13 nuclear magnetic resonance studies on native, reconstituted, and model systems. Biochemistry. 1980 Academic Article GET IT
Times cited: 6
Lipoprotein-X: proton and phosphorus-31 nuclear magnetic resonance studies on native, reconstituted, and model systems. Biochemistry. 1980 Academic Article GET IT
Times cited: 14
A new approach for evaluating risk factors in coronary artery disease: a study of lipid concentrations and severity of disease in 1847 males. Circulation. 1980 Academic Article GET IT
Times cited: 8
What's new: arguments for and against the treatment of hyperlipidemia. Texas medicine. 1980 Academic Article GET IT
Times cited: 1
Stimulation and suppression of 3-hydroxy-3-methylglutaryl coenzyme A reductase in normal human fibroblasts by high density lipoprotein subclasses. Biochimica et biophysica acta. 1980 Academic Article GET IT
Times cited: 27
The measurement of apolipoprotein A-I in human plasma by electroimmunoassay. Journal of lipid research. 1980 Academic Article GET IT
Times cited: 38
Abnormal suppression of 3-hydroxy-3-methylglutaryl-CoA reductase activity in cultured human fibroblasts by hypertriglyceridemic very low density lipoprotein subclasses. Lipids. 1980 Academic Article GET IT
Times cited: 18
Activation of lecithin:cholesterol acyltransferase by a synthetic model lipid-associating peptide. Proceedings of the National Academy of Sciences of the United States of America. 1980 Academic Article GET IT
Times cited: 56
The antigenic structure of apolipoprotein A-I in human high density lipoproteins. Radioimmunoassay using surface-specific antibodies. The Journal of biological chemistry. 1980 Academic Article GET IT
Times cited: 41
Abnormal effects of hypertriacylglycerolemic very low-density lipoproteins on 3-hydroxy-3-methylglutaryl-CoA reductase activity and viability of cultured bovine aortic endothelial cells. Biochimica et biophysica acta. 1980 Academic Article GET IT
Times cited: 37
Characterization of human high density lipoproteins by zonal ultracentrifugation. The Journal of biological chemistry. 1980 Academic Article GET IT
Times cited: 120
Serum lipoprotein structure: resonance energy transfer localization of fluorescent lipid probes. Biochemistry. 1980 Academic Article GET IT
Times cited: 45
Apolipoprotein B metabolism in normal, type IV and type V hyperlipoproteinemic subjects. Metabolism: clinical and experimental. 1980 Academic Article GET IT
Times cited: 22
The phospholipid-binding and immunochemical properties of amidinated, guanidinated and acetylated apolipoprotein A-II. Biochimica et biophysica acta. 1980 Academic Article GET IT
Times cited: 13
Relation of diet to high-density-lipoprotein cholesterol in middle-aged marathon runners, joggers, and inactive men. The New England journal of medicine. 1980 Academic Article GET IT
Times cited: 189
Immunochemistry of human very low density lipoproteins: apolipoprotein C-III. Biochemistry. 1980 Academic Article GET IT
Times cited: 10
Activation of lipoprotein lipase by synthetic fragments of apolipoprotein C-II. Annals of the New York Academy of Sciences. 1980 Academic Article GET IT
Times cited: 42
Dynamics of lipid motions in high-density lipoprotein subfractions HDL2 and HDL3: magnetic resonance studies. Annals of the New York Academy of Sciences. 1980 Academic Article GET IT
Times cited: 14
Effects of HDL subclasses on 3-hydroxy-3-methylglutaryl coenzyme A reductase in human fibroblasts. Nutrition and metabolism. 1980 Academic Article GET IT
Times cited: 3
Effects of saturated and polyunsaturated fat diets on the chemical and physical properties of lipoproteins from type V hyperlipoproteinemic subjects. Progress in food & nutrition science. 1980 Academic Article GET IT
Effects of saturated and polyunsaturated fat diets on the chemical composition and metabolism of low density lipoproteins in man. Journal of lipid research. 1980 Academic Article GET IT
Times cited: 235
Obesity--a new approach to an old person. Heart & lung : the journal of critical care. 1980 Academic Article GET IT
Times cited: 4
Phospholipid binding studies with synthetic apolipoprotein fragments. Annals of the New York Academy of Sciences. 1980 Review GET IT
Times cited: 66
The DeBakey Center. Cardiovascular Research Center bulletin. 1980 Academic Article GET IT
Tissue-cultured smooth muscle cells from normal and atherosclerotic arteries. Cardiovascular Research Center bulletin. 1980 Academic Article GET IT
Weight control and nutrition education programs in occupational settings. Public health reports (Washington, D.C. : 1974). 1980 Academic Article GET IT
Times cited: 21
Very low density lipoprotein. Removal of Apolipoproteins C-II and C-III-1 during lipolysis in vitro. The Journal of biological chemistry. 1979 Academic Article GET IT
Times cited: 41
Contribution of alpha helix formation in human plasma apolipoproteins to their enthalpy of association with phospholipids. The Journal of biological chemistry. 1979 Academic Article GET IT
Times cited: 15
Mechanism of lipid--protein interaction in the plasma lipoproteins: relationship of lipid-binding sites to antigenic sites in apolipoprotein A-II. Biochemistry. 1979 Academic Article GET IT
Times cited: 7
Binding of the chemical carcinogen, p-dimethylaminoazobenzene, by human plasma low density lipoproteins. FEBS letters. 1979 Academic Article GET IT
Times cited: 33
Lipolysis of ApoC-II deficient very low density lipoproteins: enhancement of lipoprotein lipase action by synthetic fragments of apoC-II. Biochemical and biophysical research communications. 1979 Academic Article GET IT
Times cited: 49
Cholesteryl ester and triacylglycerol fatty acids in type V hyperlipidemia. Lipids. 1979 Academic Article GET IT
Times cited: 6
Plasma lipid changes in the normal population following behavioral treatment. Journal of consulting and clinical psychology. 1979 Academic Article GET IT
Times cited: 19
Characterization of low density lipoprotein-like particle in the human aorta from grossly normal and atherosclerotic regions. Biochimica et biophysica acta. 1979 Academic Article GET IT
Times cited: 58
Are low-cholesterol diets expensive?. Journal of the American Dietetic Association. 1979 Academic Article GET IT
Times cited: 1
Effects of nicotinic acid therapy on plasma high density lipoprotein subfraction distribution and composition and on apolipoprotein A metabolism. The Journal of clinical investigation. 1979 Academic Article GET IT
Times cited: 211
Is atherosclerosis reversible?. Journal of the American Dietetic Association. 1979 Review GET IT
Times cited: 5
Apolipoprotein A-II: chemical synthesis and biophysical properties of three peptides corresponding to fragments in the amino-terminal half. Biochemistry. 1979 Academic Article GET IT
Times cited: 25
A review of the unique features of HDL apoproteins. Lipids. 1979 Academic Article GET IT
Times cited: 17
Correlation in the human aorta of APO B fractions with tissue cholesterol and collagen content. Atherosclerosis. 1979 Academic Article GET IT
Times cited: 18
Very low density and low density lipoprotein subfractions in type III and type IV hyperlipoproteinemia. Chemical and physical properties. Biochimica et biophysica acta. 1979 Academic Article GET IT
Times cited: 41
Suppression of 3-hydroxy-3-methylglutaryl-CoA reductase by low density lipoproteins produced in vitro by lipoprotein lipase action on nonsuppressive very low density lipoproteins. The Journal of biological chemistry. 1979 Academic Article GET IT
Times cited: 21
Kinetics of lipid--protein interactions: effect of cholesterol on the association of human plasma high-density apolipoprotein A-I with L-alpha-dimyristoylphosphatidylcholine. Biochemistry. 1979 Academic Article GET IT
Times cited: 84
Structure of the dimyristoylphosphatidylcholine vesicle and the complex formed by its interaction with apolipoprotein C-III: X-ray small-angle scattering studies. Biochemistry. 1979 Academic Article GET IT
Times cited: 41
A laser spectrofluorimeter for studies of cultured cells on the growth surface. Analytical biochemistry. 1979 Academic Article GET IT
Times cited: 6
A low-cholesterol menu in a steak restaurant. Journal of the American Dietetic Association. 1979 Academic Article GET IT
Times cited: 16
Dedication of the Alkek Tower, Houston, Texas: Opening and closing remarks at the scientific lectures. Cardiovascular Research Center bulletin. 1979 Academic Article GET IT
Reconstituted low density lipoprotein: a vehicle for the delivery of hydrophobic fluorescent probes to cells. Journal of supramolecular structure. 1979 Academic Article GET IT
Times cited: 88
Apo B concentration in the normal human aorta. Biochemical and biophysical research communications. 1978 Academic Article GET IT
Times cited: 32
Developing and evaluating audiovisual media for dietary education. Journal of the American Dietetic Association. 1978 Academic Article GET IT
Times cited: 1
Lipoprotein-apoprotein exchange in aqueous systems: relevance to the occurrence of apoA-I and apoC proteins in a common particle. Biochemical and biophysical research communications. 1978 Academic Article GET IT
Times cited: 26
Quantification of apoC-II and apoC-III of human very low density lipoproteins by analytical isoelectric focusing. Journal of lipid research. 1978 Academic Article GET IT
Times cited: 65
Dietary and behavioral treatment of hyperlipidemia. Comprehensive therapy. 1978 Review GET IT
Release of low density lipoprotein receptors from human fibroblasts or HeLa cells by tryptic digestion. Biochemical and biophysical research communications. 1978 Academic Article GET IT
Times cited: 4
Formation of high density lipoprotein2-like particles during lipolysis of very low density lipoproteins in vitro. Proceedings of the National Academy of Sciences of the United States of America. 1978 Academic Article GET IT
Times cited: 402
Effects of dietary saturated and polyunsaturated fat on the metabolism of apolipoproteins A-I and B. Study of a patient with type IIb hyperlipoproteinaemia. 1978 GET IT
Times cited: 9
Quantitation of apo B in human aortic fatty streaks. A comparison with grossly normal intima and fibrous plaques. Atherosclerosis. 1978 Academic Article GET IT
Times cited: 16
A comparison of two methods to investigate the metabolism of human apolipoproteins A-I and and A-II. Journal of lipid research. 1978 Academic Article GET IT
Times cited: 40
apo-C-II deficiency: a new mutant. The New England journal of medicine. 1978 Editorial Article GET IT
Times cited: 3
Detergent extraction of tightly-bound apoB from extracts of normal aortic intima and plaques. Experimental and molecular pathology. 1978 Academic Article GET IT
Times cited: 16
Effects of dietary polyunsaturated and saturated fat on the properties of high density lipoproteins and the metabolism of apolipoprotein A-I. The Journal of clinical investigation. 1978 Academic Article GET IT
Times cited: 299
Metabolism of apolipoproteins A-I and A-II and its influence on the high density lipoprotein subfraction distribution in males and females. European journal of clinical investigation. 1978 Academic Article GET IT
Times cited: 33
[Familial hypobetalipoproteinemia]. 1978 GET IT
Correlation of apolipoprotein B retention with the structure of atherosclerotic plaques from human aortas. Laboratory investigation; a journal of technical methods and pathology. 1978 Academic Article GET IT
Times cited: 34
The cyanogen bromide peptides of the apoprotein of low density lipoprotein (ApoB): its molecular weight from a chemical view. Biochemical and biophysical research communications. 1978 Academic Article GET IT
Times cited: 20
Kinetics of lipid--protein interactions: interaction of apolipoprotein A-I from human plasma high density lipoproteins with phosphatidylcholines. Biochemistry. 1978 Academic Article GET IT
Times cited: 189
The role of dietary polyunsaturated fat in lowering blood cholesterol in man. Circulation research. 1978 Review GET IT
Times cited: 62
Communication patterns in a biomedical research center. Journal of medical education. 1978 Academic Article GET IT
Times cited: 2
Dynamic properties of human high density lipoprotein apoproteins. Journal of lipid research. 1978 Academic Article GET IT
Times cited: 44
Control of 3-hydroxy-3-methylglutaryl-CoA reductase activity in cultured human fibroblasts by very low density lipoproteins of subjects with hypertriglyceridemia. The Journal of clinical investigation. 1978 Academic Article GET IT
Times cited: 54
Apoprotein exchange between human high-density-lipoprotein subfractions (high-density-lipoprotein subfractions 2 and 3) [proceedings]. Biochemical Society transactions. 1978 Academic Article GET IT
Lecithin:cholesterol acyltransferase activation and lipid binding by synthetic fragments of apolipoprotein C-I. Scandinavian journal of clinical and laboratory investigation. Supplementum. 1978 Academic Article GET IT
Times cited: 18
Plasma lipids as collateral risk factors in coronary artery disease--a study of 371 males with chest pain. Journal of chronic diseases. 1978 Academic Article GET IT
Times cited: 35
Should hyperlipidemia be treated? Available agents and clinical results. Cardiovascular Research Center bulletin. 1978 Academic Article GET IT
The influence of dietary-fat saturation on the metabolism of apolipoproteins A-I, B and C in a type-IIb hyperlipoproteinaemic subject [proceedings]. 1978 GET IT
Times cited: 2
The plasma lipoproteins: current concepts of metabolism and structure with clinical implications. Advances in experimental medicine and biology. 1978 Academic Article GET IT
The plasma lipoproteins: structure and metabolism. Annual review of biochemistry. 1978 Review GET IT
Times cited: 191
The in vitro interaction of human apolipoprotein A-I and high density lipoproteins. Biochimica et biophysica acta. 1977 Academic Article GET IT
Times cited: 50
Lipid binding by fragments of apolipoprotein C-III-1 obtained by thrombin cleavage. Biochemistry. 1977 Academic Article GET IT
Times cited: 42
Primary type V hyperlipoproteinemia in childhood. 1977 GET IT
Times cited: 3
Effects of clofibrate, nicotinic acid and diet on the properties of the plasma lipoproteins in a subject with type III hyperlipoproteinemia. 1977 GET IT
Times cited: 22
Familial hypercholesterolemia: diagnosis, metabolic defect and management. Life sciences. 1977 Review GET IT
Times cited: 2
Interaction of plasma "arginine-rich" apolipoprotein with dimyristoylphosphatidylcholine. Biochemistry. 1977 Academic Article GET IT
Times cited: 19
Activation of lipoprotein lipase by native and synthetic fragments of human plasma apolipoprotein C-II. Proceedings of the National Academy of Sciences of the United States of America. 1977 Academic Article GET IT
Times cited: 128
Apolipoprotein B retention in the grossly normal and atherosclerotic human aorta. Circulation research. 1977 Academic Article GET IT
Times cited: 41
Evaluation of the classical methods for the diagnosis of type III hyperlipoproteinemia. Klinische Wochenschrift. 1977 Academic Article GET IT
Times cited: 4
Relationship between plasma lipid concentrations and coronary artery disease in 496 patients. Circulation. 1977 Academic Article GET IT
Times cited: 101
The efficacy of lay CPR instruction: an evaluation. American journal of public health. 1977 Academic Article GET IT
Times cited: 31
Mechanism of lipid-protein interaction in the plasma lipoproteins: lipid-binding properties of synthetic fragments of apolipoprotein A-II. Biochemistry. 1977 Academic Article GET IT
Times cited: 41
Thermodynamics of lipid protein associations. Thermodynamics of helix formation in the association of high density apolipoprotein A-I (apoA-I) to dimyristoyl phosphatidylcholine. Biochimica et biophysica acta. 1977 Academic Article GET IT
Times cited: 19
Lipid-protein interactions in the plasma lipoproteins. Biochimica et biophysica acta. 1977 Review GET IT
Times cited: 202
Lipoprotein-X: a substrate for lecithin: cholesterol acyltransferase. European journal of clinical investigation. 1977 Academic Article GET IT
Times cited: 13
Characterization of baboon plasma high-density lipoproteins and of their major apoproteins. Biochemistry. 1977 Academic Article GET IT
Times cited: 22
Physical properties of the dimyristoylphosphatidylcholine vesicle and of complexes formed by its interaction with apolipoprotein C-III. Biochemistry. 1977 Academic Article GET IT
Times cited: 42
Primary structure of very low density apolipoprotein C-II of human plasma. Proceedings of the National Academy of Sciences of the United States of America. 1977 Academic Article GET IT
Times cited: 120
Isolation, chemical characterization, and biophysical properties of three different abnormal lipoproteins: LP-X1, LP-X2, and LP-X3. The Journal of biological chemistry. 1977 Academic Article GET IT
Times cited: 56
Dietary treatment of type IV hyperlipoproteinemia. JAMA. 1977 Academic Article GET IT
Times cited: 14
Influence of dietary trans-fatty acids on swine lipoprotein composition and structure. Journal of lipid research. 1977 Academic Article GET IT
Times cited: 29
Biomedical research priorities in the 1970's. Cardiovascular Research Center bulletin. 1977 Academic Article GET IT
Times cited: 1
Composition-structure-function correlations in the binding of an apolipoprotein to phosphatidylcholine bilayer mixtures. Journal of lipid research. 1977 Academic Article GET IT
Times cited: 16
Plasma lipoproteins: recent developments. Advances in experimental medicine and biology. 1977 Review GET IT
Times cited: 3
Quantification of apolipoprotein B in grossly normal human aorta. Circulation research. 1977 Academic Article GET IT
Times cited: 37
Atherosclerotic cardiovascular disease: current prospectives. Journal of chronic diseases. 1976 Editorial Article GET IT
Times cited: 2
Structure of an apolipoprotein-phospholipid complex: apoC-III induced changes in the physical properties of dimyristoylphosphatidylcholine. Biochemistry. 1976 Academic Article GET IT
Times cited: 28
Effects of intravenous phospholipid on low density lipoprotein turnover in man. European journal of clinical investigation. 1976 Academic Article GET IT
Times cited: 31
The solid phase synthesis of a protein activator for lecithin-cholesterol acyltransferase corresponding to human plasma apoC-I. Proceedings of the National Academy of Sciences of the United States of America. 1976 Academic Article GET IT
Times cited: 26
Lipoprotein structure and metabolism. Physiological reviews. 1976 Review GET IT
Times cited: 275
Drug treatment of hyperlipidemia. The American journal of medicine. 1976 Academic Article GET IT
Times cited: 40
Interaction of apoliprotein C-III with phosphatidylcholine vesicles. Dependence of aproprotein-phospholipid complex formation on vesicle structure. Biochimica et biophysica acta. 1976 Academic Article GET IT
Times cited: 9
Apo-lipoprotein localization in human atherosclerotic arteries. Advances in experimental medicine and biology. 1976 Academic Article GET IT
Times cited: 3
Comparative studies on plasma low density lipoproteins from pig and man. Comparative biochemistry and physiology. B, Comparative biochemistry. 1976 Academic Article GET IT
Times cited: 26
Introduction to the volume on dedication of the National Heart and Blood Vessel Research and Demonstration Center. Cardiovascular Research Center bulletin. 1976 Academic Article GET IT
Lipid and lipoprotein abnormalities in renal disease. Perspectives in nephrology and hypertension. 1976 Review GET IT
Times cited: 7
Solid phase radioimmunoassay of apolipoprotein B (apo B) in normal human plasma. Atherosclerosis. 1976 Academic Article GET IT
Times cited: 22
The removal of cellular lipids from Landschůtz ascites cells and smooth muscle cells in culture. Advances in experimental medicine and biology. 1976 Academic Article GET IT
Times cited: 3
A comparative study on the removal of cellular lipids from Landschütz ascites cells by human plasma apolipoproteins. The Journal of biological chemistry. 1975 Academic Article GET IT
Times cited: 79
Contrasting effects on plasma lipoproteins of intravenous versus oral administration of a triglyceride-phospholipid emulsion. European journal of clinical investigation. 1975 Academic Article GET IT
Times cited: 18
Interaction of human plasma apolipoproteins and phospholipids. Semi-quantitative studies using polyacrylamide gel electrophoresis. Biochimica et biophysica acta. 1975 Academic Article GET IT
Times cited: 9
Effect of the human plasma apolipoproteins and phosphatidylcholine acyl donor on the activity of lecithin: cholesterol acyltransferase. Biochemistry. 1975 Academic Article GET IT
Times cited: 264
Localization patterns of plasma apolipoproteins in human atherosclerotic lesions. Circulation research. 1975 Academic Article GET IT
Times cited: 66
Basal and postprotein insulin and glucagon levels during a high and low carbohydrate intake and their relationships to plasma triglycerides. Diabetes. 1975 Academic Article GET IT
Times cited: 19
Lipoproteins in atherosclerotic lesions. Localization by immunofluorescence of apo-low density lipoproteins in human atherosclerotic arteries from normal and hyperlipoproteinemics. Archives of pathology. 1975 Academic Article GET IT
Times cited: 57
Bovine serum albumin. Study of the fatty acid and steroid binding sites using spin-labeled lipids. The Journal of biological chemistry. 1975 Academic Article GET IT
Times cited: 93
The primary structure of human plasma high density apolipoprotein glutamine I (ApoA-I). I. The amino acid sequence of cyanogen bromide fragment II. The Journal of biological chemistry. 1975 Academic Article GET IT
Times cited: 19
The primary structure of human plasma high density apolipoprotein glutamine I (ApoA-I). II. The amino acid sequence and alignment of cyanogen bromide fragments IV, III, and I. The Journal of biological chemistry. 1975 Academic Article GET IT
Times cited: 62
The mechanism of lipid-binding by plasma lipoproteins. Molecular and cellular biochemistry. 1975 Review GET IT
Times cited: 37
Lipoproteins: structure and function. Annual review of biochemistry. 1975 Review GET IT
Times cited: 144
The interaction of apolipoprotein-alanine (apoC-III) with lipids: study of structural features required for binding. Advances in experimental medicine and biology. 1975 Academic Article GET IT
Times cited: 1
Effects of maleylation on the lipid-binding and immunochemical properties of human plasma high density apolipoprotein-A-II. Biochemical and biophysical research communications. 1974 Academic Article GET IT
Times cited: 6
A new fluorimetric procedure for the detection and quantitation of organic compounds in thin-layer chromatography. Journal of chromatography. 1974 Academic Article GET IT
Times cited: 49
Structure of the major complex formed by interaction of phosphatidylcholine bilamellar vesicles and apolipoprotein-alanine (APO-C-III). Biochemistry. 1974 Academic Article GET IT
Times cited: 31
Pseudohomozygous type II hyperlipoproteinemia. The Journal of pediatrics. 1974 Academic Article GET IT
Times cited: 40
The requirement for lipid fluidity in the formation and structure of lipoproteins: thermotropic analysis of apolipoprotein-alanine binding to dimyristoyl phosphatidylcholine. Biochemical and biophysical research communications. 1974 Academic Article GET IT
Times cited: 30
The anatomic substrate of complete left bundle branch block. Circulation. 1974 Academic Article GET IT
Times cited: 41
The primary structure of high density apolipoprotein-glutamine-I. Proceedings of the National Academy of Sciences of the United States of America. 1974 Academic Article GET IT
Times cited: 72
The interaction of apolipoprotein-serine with phosphatidylcholine. The Journal of biological chemistry. 1974 Academic Article GET IT
Times cited: 46
The primary structure of apolopoprotein-serine. The Journal of biological chemistry. 1974 Academic Article GET IT
Times cited: 63
Localization of low-density lipoproteins in atherosclerotic lesions from human normolipemics employing a purified fluorescent-labeled antibody. Biochimica et biophysica acta. 1974 Academic Article GET IT
Times cited: 51
Prudent eating after 40. Relationship of diet to blood lipids and coronary heart disease. Geriatrics. 1974 Academic Article GET IT
Times cited: 2
A molecular theory of lipid-protein interactions in the plasma lipoproteins. FEBS letters. 1974 Academic Article GET IT
Times cited: 487
Phospholipids in biology and medicine (second of two parts). The New England journal of medicine. 1974 Review GET IT
Times cited: 12
Phospholipids in biology and medicine (first of two parts). The New England journal of medicine. 1974 Academic Article GET IT
Times cited: 17
Human plasma high density lipoprotein. Interaction of the cyanogen bromide fragments from apolipoprotein glutamine II (A-II) with phosphatidylcholine. The Journal of biological chemistry. 1973 Academic Article GET IT
Times cited: 27
Isolation and characterization of the cyanogen bromide fragments from the high-density apolipoprotein glutamine I. Biochemistry. 1973 Academic Article GET IT
Times cited: 32
Human high density lipoprotein, apolipoprotein glutamine II. The immunochemical and lipid-binding properties of apolipoprotein glutamine II derivatives. The Journal of biological chemistry. 1973 Academic Article GET IT
Times cited: 44
Ileal bypass in the treatment of hyperlipoproteinaemia. Lancet (London, England). 1973 Academic Article GET IT
Times cited: 15
Application of laser self-beat spectroscopic technique to the study of solutions of human plasma low-density lipoproteins. Biochemistry. 1973 Academic Article GET IT
Times cited: 16
Chemical synthesis and biochemical properties of peptide fragments of apolipoprotein-alanine. Proceedings of the National Academy of Sciences of the United States of America. 1973 Academic Article GET IT
Times cited: 36
A comparaive study of the effects of chemical modification on the immunochemical and optical properties of human plasma low-density lipoprotein(s) and apoproteins. The Biochemical journal. 1973 Academic Article GET IT
Times cited: 20
Dietary aspects of hyperlipidemia. Journal of the American Dietetic Association. 1973 Review GET IT
Times cited: 2
A comparison of the major apolipoprotein from pig and human high density lipoproteins. The Journal of biological chemistry. 1973 Academic Article GET IT
Times cited: 68
Interaction of an apolipoprotein (apoLP-alanine) with phosphatidylcholine. Biochemistry. 1973 Academic Article GET IT
Times cited: 252
Interaction of phosphatidylcholine and apolipoprotein-alanine: electron microscopic studies. Biochimica et biophysica acta. 1973 Academic Article GET IT
Times cited: 32
Type V hyperlipoproteinaemia. Clinics in endocrinology and metabolism. 1973 Review GET IT
Times cited: 6
Methods for studying lipid-protein interactions. Cardiovascular Research Center bulletin. 1973 Academic Article GET IT
Times cited: 2
Plasma lipoproteins and atherosclerosis in man: an immunohistochemical study. Cardiovascular Research Center bulletin. 1973 Academic Article GET IT
Times cited: 1
Isolation of a helical, lipid-binding fragment from the human plasma high density lipoprotein, apoLP GLN-I. Biochemical and biophysical research communications. 1972 Academic Article GET IT
Times cited: 19
A study of the cystine-containing apolipoprotein of human plasma high density lipoproteins: characterization of cyanogen bromide and tryptic fragments. Biochimica et biophysica acta. 1972 Academic Article GET IT
Times cited: 33
Identification of the lipid-binding cyanogen bromide fragment from the cystine-containing high density apolipoprotein, APOLP-GLN-II. Biochemical and biophysical research communications. 1972 Academic Article GET IT
Times cited: 20
Studies on the protein defect in Tangier disease. Isolation and characterization of an abnormal high density lipoprotein. The Journal of clinical investigation. 1972 Academic Article GET IT
Times cited: 52
Circular dichroic studies of human plasma retinol-binding protein and prealbumin. Biochimica et biophysica acta. 1972 Academic Article GET IT
Times cited: 18
Evidence for the identity of the major apoprotein in low density and very low density lipoproteins in normal subjects and patients with familial hyperlipoproteinemia. The Journal of clinical investigation. 1972 Academic Article GET IT
Times cited: 55
The influence of lipid on the conformation of human plasma high density apolipoproteins. The Journal of biological chemistry. 1972 Academic Article GET IT
Times cited: 106
On the protein defect in abetalipoproteinemia. The New England journal of medicine. 1971 Academic Article GET IT
Times cited: 69
Observations on the conformation of human serum high-density lipoproteins using infrared spectroscopy, circular dichroism, and electron spin resonance. Biochemistry. 1970 Academic Article GET IT
Times cited: 19
Electron spin resonance studies of lipid-protein interaction in human serum lipoproteins. Proceedings of the National Academy of Sciences of the United States of America. 1970 Academic Article GET IT
Times cited: 18
Recent studies on the structure of human serum low-and high-density lipoproteins. Proceedings of the National Academy of Sciences of the United States of America. 1969 Academic Article GET IT
Times cited: 23
Application of electron spin resonance to the study of the structure of human serum lipoproteins. Biochemical and biophysical research communications. 1969 Academic Article GET IT
Times cited: 16
Conformation of human serum high density lipoprotein and its peptide components. Nature. 1969 Academic Article GET IT
Times cited: 13
Human serum beta lipoprotein and beta apoprotein. Nature. 1969 Academic Article GET IT
Times cited: 4
Beta-apoprotein sufficiency and function. The New England journal of medicine. 1969 Academic Article GET IT
Times cited: 1
Partial delipidation of human serum beta-lipoprotein by sodium decyl sulfate. Biochimica et biophysica acta. 1969 Academic Article GET IT
Times cited: 8
Stimulatory effects of inosine and deoxyinosine on the incorporation of uracil-2-14-C, 5-fluorouracil-2-14-C, and 5-bromouracil-2-14-C into nucleic acids by Ehrlich ascites tumor cells in vitro. Cancer research. 1969 Academic Article GET IT
Times cited: 49
Preparation and properties of an apoprotein derivative of human serum beta-lipoprotein. Lipids. 1968 Academic Article GET IT
Times cited: 5
Human serum beta-lipoprotein. Nature. 1968 Academic Article GET IT
Times cited: 3
Observations on the conformation of human beta lipoprotein: evidence for the occurrence of beta structure. Proceedings of the National Academy of Sciences of the United States of America. 1968 Academic Article GET IT
Times cited: 28
The structure and properties of human beta-lipoprotein and beta-apoprotein. Biochemical and biophysical research communications. 1968 Academic Article GET IT
Times cited: 16
Human serum beta-lipoprotein: preparation and properties of a delipidated, soluble derivative. Biochemical and biophysical research communications. 1968 Academic Article GET IT
Times cited: 13
On the mechanism of the nucleoside stimulation of amino acid incorporation into protein of Ehrlich ascites tumor cells in vitro. Cancer research. 1967 Academic Article GET IT
Times cited: 2
The metabolism of purine compounds in Ehrlich ascites tumor cells: evidence for a salvage pathway of inosine metabolism. Biochimica et biophysica acta. 1967 Academic Article GET IT
Times cited: 6
Isolation and analysis of renal bismuth inclusions. Toxicology and applied pharmacology. 1965 Academic Article GET IT
Times cited: 11
Spectrophotometric and manometric studies of NADPH and NADH oxidase activities of rat liver microsomes: effects of drugs and adenine nucleotides. Biochemical pharmacology. 1965 Academic Article GET IT
Times cited: 6
NUCLEOSIDE METABOLISM IN EHRLICH ASCITES TUMOR CELLS: PHOSPHOROLYSIS OF PURINE NUCLEOSIDES. Biochimica et biophysica acta. 1964 Academic Article GET IT
Times cited: 9
Induction of fructose-1,6-diphosphatase activity in Escherichia coli. Biochemical and biophysical research communications. 1962 Academic Article GET IT
Times cited: 4
Properties of a new glyoxylate reductase from leaves. The Biochemical journal. 1962 Academic Article GET IT
Times cited: 39
The metabolism of C2 compounds in micro-organisms. 7. Preparation and properties of crystalline tartronic semialdehyde reductase. The Biochemical journal. 1961 Academic Article GET IT
Times cited: 20
Crystalline tartronic semialdehyde reductase from Pseudomonas ovalis Chester. Biochimica et biophysica acta. 1961 Academic Article GET IT
Times cited: 1
The metabolism of C2 compounds in micro-organisms. 6. Synthesis of cell constituents from glycollate by Pseudomonas sp. The Biochemical journal. 1961 Academic Article GET IT
Times cited: 52
Formation of malate from glycollate by Pseudomonas ovalis Chester. Nature. 1959 Academic Article GET IT
Times cited: 8
Effect of growth substrates on isocitratase formation by Pseudomonas ovalis Chester. Nature. 1958 Academic Article GET IT
Times cited: 4

more ...

less ...

Background

education and training

M.D., Vanderbilt University School of Medicine 1965
D.Phil., Oxford University (United Kingdom) 1961
B.A., Vanderbilt University 1957

Contact

full name

Antonio M Gotto

primary email

amg2004@med.cornell.edu

webpage

Clinical Profile

VIVO Weill Cornell Medical College

Antonio M Gotto Provost for Medical Affairs and Dean Emeritus

Publications

selected publications

Background

education and training

Contact

full name

primary email

webpage

Phone

Publications

selected publications

Background

education and training

Contact

full name

primary email

webpage